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I. Meyer-Schuster rearrangement 
 
Meyer-Schuster rearrangement is an atom economical reaction, in which α,β-unsaturated 
carbonyl compounds are formed from propargylic alcohols and their derivatives by formal 
migration of the carbonyl group. Brønsted acids have been used traditionally as stoichiometric 
catalysts, but more recently, several Lewis acids both salts and metal complexes, have become 
popular due to their selectivity and mild conditions applied. Also oxo-metal complexes are often 
used despite the high reaction temperature needed. 
 
In this thesis, various manners and catalysts for the Meyer-Schuster rearrangement are 
reviewed. Reactivity of different substrates and practicality of several types of catalysts are 
evaluated. In addition, different reaction mechanisms are discussed, as they are highly substrate 
and catalyst-dependent. Propargylic alcohols have two functional groups, in which the catalysts 
can coordinate according to their characteristics. Especially gold compounds, which are soft 
Lewis acids, have gained interest due to their specific coordination ability. 
 
 
II. Synthesis of potential FtsZ inhibitors 
 
FtsZ, which is a bacterial homologue for tubulin, is essential in the cell division. It polymerizes 
into a dynamic ring structure, which constricts to separate the new daughter cells. Being FtsZ 
protein-directing compounds, 3-methoxybenzamide derivatives have been noticed to inhibit 
growth of certain bacteria. 
 
In this work, a set of molecules was synthesized based on PC190723, which is a 3-
methoxybenzamide derivative. In order to study interactions between the protein and the 
inhibitors, fluorescent groups were attached. Polymer sedimentation tests and fluorescence 
spectroscopy were used to study shortly the biological behavior of the products. It was 
discovered that one of the products is a polymer-stabilizing and thus, FtsZ activity inhibiting 
compound. 
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Abbreviations 
Ac acetate 
acac acetylacetone 
BMIM 1-butyl-3-methylimidazolium 
Bn benzyl 
Bu butyl 
Bz benzoyl 
cat. catalytical 
Cp cyclopentadienyl 
Cp* pentamethylcyclopentadienyl 
CSA camphorsulfonic acid 
Cy cyclohexane 
DBN 1,5-diazabicyclo[4.3.0]non-5-ene 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
DCM dichloromethane 
DFT density functional theory 
DIPEA N,N-diisopropylethylamine 
DMA dimethylacetamide 
DMF dimethylformamide 
eq equivalent 
Et ethyl 
HPA heteropoly acid 
HSAB Hard-Soft Acid-Base Principle 
i-Pr isopropyl 
IPr N,N´-bis(2,6-diisopropylphenyl)imidazol-2-ylidene 
ItBu N,N´-bis(tert-butyl)imidazol-2-ylidene 
L ligand 
Me methyl 
M-S Meyer-Schuster 
Ms methanesulfonic acid 
MW microwave 
NHC N-heterocyclic carbene 
  
n-Pr propyl 
Ph phenyl 
PTSA p-toluenesulfonic acid 
rt room temperature 
SN2’ nucleophilic conjugate substitution 
TA 1,2,3-triazole 
t-Bu tert-butyl 
t-BuXPhos 2-di-tert-butylphosphino-2′,4′,6′-triisopropylbiphenyl 
TFA trifluoroacetic acid 
THF tetrahydrofurane 
Tf trifuoromethanesulfonate 
Ts p-toluenesulfonate 
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1. Introduction 
α,β-unsaturated ketones and aldehydes are valuable synthetic precursors. Aldol condensation is a 
textbook example of preparing α,β-unsaturated carbonyl compounds by atom-economical way, but 
harsh conditions and several side products limit its general applicability. Wittig reaction and its 
modifications offer another method for construction of olefins. In Horner-Wadsworth-Emmons 
reaction phosphonate carbanions react with aldehydes or ketones, and in Peterson olefination α-
silyl carbanions are used instead. Despite milder reaction conditions, one has to cope with waste 
side products, which is not in accordance with the green chemistry guidelines. In addition, these 
olefination methods are not necessarily suitable with bulky and demanding substrates. 
Meyer-Schuster rearrangement (later M-S) gives α,β-unsaturated carbonyl compounds from 
propargylic alcohols conveniently by acid treatment.1 A formal 1,3-hydroxyl shift followed by 
tautomerization is carried out by Brønsted acid or more recently, Lewis acid often used in catalytic 
amounts (Scheme 1). The M-S rearrangement is atom-economical and thus, very recommendable 
reaction, which has gained more interest now that the catalytic methods have advanced. 
 
 
Scheme 1. Meyer-Schuster rearrangement. 
 
There are several mechanisms for the M-S rearrangement, depending on the catalyst and 
conditions. Thus, sometimes using the term “Meyer-Schuster rearrangement” for all the reactions 
of this group is misleading, although the result is the same.  
Propargylic alcohols are widely available and affordable. They can be prepared easily by 
alkynylation of an aldehyde or a ketone. While Brønsted acids act by protonation followed by a 
dehydration-hydration mechanism, Lewis acids coordinate either with the hydroxyl group or the 
alkyne, depending on their tendencies (Figure 1).2 
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Figure 1. Functionalities of propargylic alcohol. 
 
This thesis tries to shed light on the methods and mechanisms underlying the M-S rearrangement. 
The structure of the review is based on different groups of catalysts. The M-S reactions, which lead 
to the formation of α,β-substituted ketones, aldehydes or acetates, are studied almost exclusively. 
Some examples of alternative pathways, for example halogen-trapped intermediates, have been 
added, if they exhibit special insight into the mechanism, stereoselectivity or the catalyst used. The 
M-S intermediates can undergo dozens of reactions, depending on substrates, solvents and 
catalysts, and exploiting the M-S rearrangement in cascade reactions has been under intense study 
recently.3, 4 
 
2. Brønsted acids and early methods 
The first examples of the Meyer-Schuster rearrangement involved strong Brønsted acids in 
stoichiometric amounts and often heating.1, 5 Acid-induced protonation and subsequent 
dehydration of the propargylic alcohol gives an allenic cation (4) (Scheme 2). The allenol formed by 
hydration is tautomerized into the α,β-unsaturated carbonyl compound (2). 
 
 
Scheme 2. Mechanism for the Brønsted acid-catalyzed Meyer-Schuster rearrangement.5 
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Some examples of the acids used are sulfuric6 and hydrochloric acid, p-toluenesulfonic and 
benzenesulfonic acid, acetic, formic and oxalic acid. These conditions often result too harsh for 
many compounds, but a strong acid can be a convenient and easy choice in some cases. For 
example, Aiken et al. used trifluoroacetic acid at room temperature for a tertiary propargylic 
alcohol, when constructing naphtols (Scheme 3).7 The reaction in toluene gave good to excellent 
yields. 
 
 
Scheme 3. M-S reaction with trifluoroacetic acid.7 
 
In strong acid-catalyzed reactions, E and Z isomers are formed in varying proportions, the E isomer 
being thermodynamically more stable. A special example of formation of a Z isomer was offered by 
Egi et al.8 The group studied heteropoly acids (HPA) as M-S catalysts. HPAs are stronger than the 
usual inorganic acids, such as HCl, H2SO4, CF3SO2H.9 They are non-toxic, stable and easy to handle. 
Keggin-type HPAs have a general formula Hn[XM12O40], in which X is the central heteroatom and M 
is the addenda atom (W, Mo or V). Properties of the HPAs can easily be tuned by varying the 
components. The group noticed that the commercially available H3[PMo12O40]∙n H2O afforded 89% 
of an enone with basically complete E selectivity (Scheme 4). Surprisingly, changing the cation to 
silver, mostly Z isomer was obtained. It was also noticed that the Z isomer is the initial product in 
either case, due to the bulkiness of the catalyst, and subsequent isomerization occurs by treatment 
with H3[PMo12O40]∙n H2O. 
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Scheme 4. Heteropoly acid-catalyzed M-S rearrangement.8 
 
In general, the Brønsted acid method is not usually selective, and it suffers from degradation and 
side reactions. The most famous side reaction, Rupe rearrangement, can occur, when the substrate 
bears a hydrogen in a β-position from the hydroxyl functionality.10 Of the two rearrangements, 
Rupe is preferred over M-S due to lower energy.5 Mechanistically, the dehydrated intermediate 
(12) undergoes β-elimination to afford the enyne intermediate 13 (Scheme 5). Hydration provides 
an α,β-unsaturated carbonyl compound (16), which is a structural isomer for the M-S product. 
 
 
Scheme 5. Mechanism for the Rupe rearrangement.5 
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3. Soft Lewis acids 
According to the Hard-Soft Acid-Base Principle (HSAB), ions and elements are classified according 
to their tendencies to interact with certain chemical species.11 “Hard” species are small, highly 
charged and weakly polarizable. “Soft” species have naturally opposite characteristics. Hard bases 
have stronger tendency to react with hard acids and soft bases with soft acids. Thus, behavior, and 
in this context, coordination preferences of a species can be predicted. In propargylic alcohols, the 
hydroxyl group represents a hard species and the triple bond a soft species (see Figure 1). 
Late transition metals and their ions tend to be soft acids, which means that they prefer 
coordinating to acetylene over hydroxide. For this reason, gold(I), gold(III), silver(I) and mercury(I) 
compounds have been attractive candidates for selective activation of propargylic alcohols towards 
the M-S rearrangement. Nevertheless, gold(III) has been shown to be more oxophilic, while gold(I) 
is π-philic.12, 13 Gold(III) has smaller diameter and less electrons than gold(I) and is, thus, somewhat 
harder.14 This selectivity might explain product formation in some cases. 
 
3.1 Common features of gold catalysts 
In general, reactions with gold catalysts require only mild conditions, and a broad selection of 
ligands is available, of which the most common ones are phosphines and carbenes.15 Gold 
complexes are tolerant of oxygen and water, an exception being gold(III) halogen salts, which are 
hygroscopic. Gold can be employed as inorganic salts, the most commonly AuCl3 and AuCl, or 
organic complexes, with the oxidation state +I being the most popular. Gold(I) compexes are often 
used as precatalysts of the form LnAuX. The ligand X can be exchanged into a loosely coordinating 
counterion, which is usually offered by a silver(I) salt, for example AgOTf and AgBF4. The formation 
of the cationic gold species LnAu+X- enables higher electrophilicity of gold, and the X- ligand can be 
substituted by a substrate. The more loosely coordinating the counteranion, the more acidic the 
active gold complex. Importantly, silver salts can play an unpredicted role in the gold(I)-catalyzed 
reaction and lead to unwanted side reactions. Yet, there are gold(I) complexes, which do not require 
use of silver salts or other activating co-catalysts. For example, LAuNTf2-type catalysts have been 
used for the M-S rearrangement.16 
Gold catalysts do not normally act through a redox cycle, like other transition metal catalysts, but 
they activate the substrate by coordination. They are strong Lewis acids, and the exceptional ability 
to activate carbon-carbon triple bonds can be exploited in conducting the M-S rearrangement 
selectively.17 
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3.2 Meyer-Schuster rearrangement with gold catalysts 
Gold(III) chloride gave only moderate results in the M-S rearrangement of γ-phenyl-substituted 
propargylic alcohols, as dehydrated enynes were major side products.2 Instead, the acetylene group 
can be activated by incorporating an electron-donating ethoxy group to enhance coordination of 
gold. Electron-rich alkoxyacetylenes underwent the M-S rearrangement efficiently, and sterically 
demanding side groups were well tolerated. As a drawback, high catalyst loading of 5 mol% was 
needed, and low stereochemical control was achieved. A two-stage strategy for the synthesis of 
α,β-unsaturated esters includes the M-S reaction as the second step, a straightforward acetylide 
addition to ketones being the first step (Scheme 6). 
 
 
Scheme 6. Two-step olefination of ketones with gold(III) chloride.2 
 
Also Rieder et al. tested AuCl3 for ethoxy-activated substrates, but as it resulted capricious, other 
method was used instead.18 NaAuCl4∙2 H2O (5 mol%) has also given M-S products.13 
Owing to the success with the alkynylation-rearrangement by AuCl3, the Dudley group studied a set 
of secondary propargylic alcohols with ethoxy activation.19 AuCl/AgSbF6 was the best combination, 
and together with ethanol, α,β-unsaturated esters were achieved with high yields (Scheme 7). E-
selectivity was varying, but it could be further enhanced by addition of camphorsulfonic acid. Also 
one example of tertiary substrate was offered with 92% yield, thus the method could be expected 
to work with a wider range of tertiary alcohols as well. The reaction proceeds in THF-CH2Cl2 mixture 
at room temperature. The mechanism is proposed to involve substitution by ethanol to form the 
1,1-diethoxyallene (21) followed by the formation of the 1,1-diethoxyalken-1-ol (22). When ethanol 
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was substituted by n-propanol, a 1:1 mixture of ethyl and n-propyl esters was achieved (Scheme 8). 
This observation supports the necessity of ethanol in the reaction. 
 
 
Scheme 7. M-S rearrangement with AuCl/AgSbF6.19 
 
 
 
Scheme 8. Incorporation of n-propanol.19 
 
For less activated propargylic alcohols, other gold catalysts are needed. In the first reports for the 
propargylic alcohols, which do not bear an ethoxy group, conversion to corresponding acetates was 
required.16, 20 The Zhang group used the commercially available cationic [PPh3AuNTf2] (NTf2 = 
triflimide) for the M-S rearrangement of propargylic acetates. Also other phosphine ligands were 
suitable. The reaction proceeded neatly and with high E-selectivity for internal substrates with a 
wide range of alkyl and aryl functionalities (Scheme 9). In the case of terminal propargylic acetates, 
hydration of the triple bond occurred. For secondary propargylic acetates, 2 mol% of catalyst in 2-
butanone was sufficient. Tertiary substrates were prone to dehydration and other side reactions. 
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Still, 5 mol% of [PPh3AuNTf2] in acetonitrile/H2O (80:1) gave very good yields. Acetonitrile is 
assumed to slow down the reaction through coordination and thus prevent side reactions, like 
elimination. 
Gold has a dual role in activating both the triple bond during the 1,3-shift of the propargylic ester 
(25), and the subsequent alkenylacyloxocarbenium intermediate (27) (Scheme 9).16, 20 In addition 
to hydrolysis, the carbenium (27) can attack to various electrophiles resulting in intramolecular 
cyclizations21  and rearrangements22, or formation of α-iodoenones,23 to mention a few. The 
catalyst in wet butanone with t-butanol was used in the synthesis of the lower side chains of 
prostaglandins.24 Addition of t-butanol was observed to suppress desilylation of the hydroxyl 
protection. 
 
 
Scheme 9. PPh3AuNTf2-catalyzed M-S reaction of propargylic acetates.16 
 
Pennell et al. investigated generation of boron enolates from alkynes catalyzed by PPh3AuNTf2 using 
4-methoxyphenylboronic acid as an additive.25, 26 Instead of trapping the cyclic enolate, they 
obtained a β-hydroxyketone and an enone. Using methanol as the protic additive instead of boronic 
acid, the enone was acquired exclusively. A general procedure for the reaction of secondary and 
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tertiary propargylic alcohols with 1-2 mol% cationic gold(I) catalyst, in the presence of 1 equivalent 
of methanol, gives moderate to high yields (Scheme 10). The method worked notably well also for 
alkyl-substituted secondary and tertiary substrates. Secondary substrates gave better results than 
tertiary, and the dimethylamino phenyl-substituted alcohol with 15% yield was the only 
incompatible over the 29 tested substrates. Nitrogen-containing substrates tend to be unreactive 
due to coordination of gold with nitrogen and following inactivation. Primary substrates gave some 
methanol addition products in addition to the enone. This could be circumvented by using boronic 
acid instead.  
The mechanism for the MeOH-aided rearrangement is shown in Scheme 10. The carbonyl group is 
formed by addition of methanol. 
Addition of p-methoxyphenylboronic acid to the enone obtained from Au/MeOH reaction increased 
the E/Z ratio significantly. This can be reasoned by the formation of a cyclic boronate intermediate 
(33), which determines the conformation (Scheme 11). The mechanism with the aid of boronic acid 
resembles the 3,3-rearrangement mechanism of the propargylic acetate (see Scheme 9).  
Terminal propargylic alcohols yielded α-hydroxyketones but, interestingly, α,β-unsaturated 
aldehydes together with α-methoxyketones were obtained with a catalyst batch possibly 
contaminated with silver salt, which indicates a two-step reaction catalyzed by two different 
metals. 
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Scheme 10. PPh3AuNTf2-catalyzed M-S reaction of propargylic alcohols.26 
 
Scheme 11. Isomerization of Z-product by boronic acid treatment.26 
 
During the catalyst screening by the Zhang group, [PPh3AuCl]/AgSbF6 resulted unstable.16 Still, 
[PPh3AuCl] precatalyst is often a suitable option, and it can be activated by various salts. Silver(I) 
triflate was used by Mou et al. in a rearrangement/cyclization cascade reaction.27 Lee et al. screened 
several catalysts for their alkyl-chained substrate, and 5 mol% [PPh3AuCl]/AgOTf resulted the most 
efficient, but no stereocontrol was noticed.28 Due to more rapid conversion of substrates with a 
hydrogen in the α-position to the alkyne, the group proposed a cumulene intermediate caused by 
dehydration of the Au-coordinated propargylic substrate (Scheme 12). This was also supported by 
the unreactivity of double-substituted propargylic alcohols. Nevertheless, Nolan and co-workers 
showed that M-S products are obtained even in the absence of the α-hydrogen, and they discarded 
the cumulene-involving mechanism.29 
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Scheme 12. Formation of the cumulene intermediate.28 
 
Kim et al. developed a tandem synthesis of enamides starting from propargylic aldehydes (Scheme 
13).30 A phosphine-based gold complex [Me4-t-BuXPhosAuCl] (L = 2-di-tert-butylphosphino-3,4,5,6-
tetramethyl-2’,4’,6’-triisopropyl-1,1’-biphenyl, 40) with AgOTf was used to catalyze both the 
nucleophilic addition of the amide to the aldehyde and the M-S rearrangement of the resulting 
propargylic hemiaminal. Decrease in solvent polarity increased the Z/E ratio due to intramolecular 
hydrogen bonding between the amide proton and the carbonyl oxygen of the ketone. Enamides are 
important intermediates in synthesis, but traditionally their syntheses have been accompanied by 
several difficulties. 
 
Scheme 13. Tandem enamide synthesis with LAuCl/AgOTf.30 
 
The groups of Shin and Glorius introduced independently a fascinating method to activate the 
[PPh3AuCl] precatalyst during tandem M-S rearrangement/aryl coupling.31, 32 Au(I) is oxidized to 
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active Au(III) by light-induced Ru-catalyzed redox cycle, which introduces an aryl ligand into the 
[LnAu(I)X] complex (Scheme 14). After the M-S rearrangement, reductive elimination gives the 
arylated enone 42. 
 
 
Scheme 14. Reductive elimination step of Au-redox cycle.32 
 
N-heterocyclic carbene-liganded gold complex [(NHC)AuCl] together with a silver(I) salt in THF/H2O 
was used as a catalyst by the Nolan group for the M-S reaction of propargylic acetates.33 Later, they 
achieved to apply the catalyst for propargylic alcohols by changing the solvent system into 
MeOH/H2O.29 The most suitable ligands were IPr and ItBu (43-45 in Figure 2). The catalyst was 
activated with AgSbF4, though AgBF4 and AgPF6 showed similar potential. A broad variety of 
conjugated enones were obtained from electron-rich and electron-withdrawing aryl-substituted 
compounds, as well as from unactivated secondary propargylic alcohols and acetates (Scheme 15). 
The common thing for all the substrates was the aryl substituent in either end of the molecule. Two 
examples of alkyl-substituted secondary substrates gave only 58% and 28% yields. The special 
feature in the acetate method was the reactivity of terminal alkynes, which gave poor results as 
free alcohols. 
 
 
Figure 2. Successful NHC-ligands. 
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Scheme 15. Gold-NHC complex-catalyzed M-S rearrangement.29 
 
Water was found to be essential for the reactions. Anhydrous conditions have been noticed to lead 
to formation of indenes.34 The group suggested that instead of activating the carbon-carbon triple 
bond, the catalyst activates a water molecule to facilitate its attack (Figure 3). In their suggested 
SN2’ mechanism based on DFT calculations, the active [(NHC)AuOH] species 46 coordinates via the 
oxygen atom to the electron-deficient end of the triple bond offering the carbonyl group (Scheme 
16). They postulated that an allene could not be an intermediate, like in 3,3-rearrangement, 
because an isolated allene did not react under the earlier reaction conditions (Scheme 17).20 Also, 
in THF/H2O propargylic methyl ether reacted, while propargylic alcohol remained unreactive. As a 
methoxy group is not able to undergo 3,3-rearrangement, it was tempting to exclude that 
mechanism. 
 
 
Figure 3. Proposed active NHC-catalyst.33 
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Scheme 16. Suggested SN2' mechanism with NHC-gold.33 
 
 
 
Scheme 17. Suggested evidence for the incorporation of the [NHC-Au-OH] active species and the absence of 
3,3-rearrangement..33 
 
Nevertheless, the group succeeded with the reaction of propargylic alcohols using mixture of 
methanol and water at 60 °C.29 This suggests that methanol plays a role in this case, or THF as a 
solvent was a bad choice. On the other hand, with alkoxy-substituted substrates, quantitative 
transesterification with methanol was observed. Thus, the mechanism suggested by the Dudley 
group19 (see Scheme 8) can be discarded in the case of NHC-liganded gold. 
Later, the Nolan group defined that the active species cannot be the gold hydroxyl complex due to 
low activity of the isolated complex in the absence of protic acid activator HBF4.34 Instead, the 
catalyst is [(NHC)Au]+, which is formed from [(NHC)AuOH] via the dinuclear species [{Au(NHC)}2(μ-
OH)]+ activated by a Brønsted acid.35 The precatalyst [(NHC)AuOH] is prepared easily, and expensive 
silver additives are not needed. Still, NHC ligands are expensive. Additionally, other DFT calculations 
by the Nolan group36 for NHC ligands and acetate substrates suggest coordination of gold with a 
triple bond, enabling the 1,3-shift via a cyclic intermediate, like in the previously depicted case of 
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propargylic acetate (see Scheme 9). The SN2’ mechanism cannot be excluded at this point, though. 
The exact mechanism for propargylic alcohols remained unclear. 
In addition to Nolan’s preliminary work with IPr ligand, it has been used in the synthesis of 
prostanoids, irones and α-ionones, as well as in M-S rearrangement of propargylic acetates 
followed by α-fluorination.37, 38, 39, 40 IPr was used also in a tandem one-pot synthesis of β-
disubstituted ketones.41 The M-S rearrangement of a secondary alcohol was followed by 
asymmetric boronic acid 1,4-addition. Choosing an orthogonal ligand system of gold and rhodium 
was the key to success for the first known Au(I)/Rh(I) tandem reaction. 
Shi and co-workers introduced a 1,2,3-triazole coordinated gold(I) complex (TA-Au) (Scheme 18).42, 
43, 44 In addition to being air, moisture and thermally stable, the complex was promoted as a cheaper 
option compared with the NHC ligands. However, it bears a counterion, which is introduced by a 
silver(I) salt. The precatalyst [Ph3P-Au-triazole]+·X- reveals the active species [(Ph3P)Au]+, and the 
role of the triazole counter ligand is to dynamically stabilize the gold catalyst from degradation. 
Since simple [(Ph3P)Au]+ catalysts suffer from low stability and oxidation,42, 45 development of 
bulkier phosphorus ligands was one approach to circumvent the problem. Triazole ligands, instead, 
allow the use of inexpensive Ph3P. 
M-S rearrangement for propargylic acetates and alcohols has been made with TA-Au (Scheme 18).44 
It was suggested that an equilibrium between the neutral (54) and ionized (55) forms of TA-Au and 
liberation of HOTf causes hydration of the allene after the 1,3-shift. A large group of secondary 
substrates were reactive, including terminal alkyne, as well as t-butyl-substituted propargylic 
acetate, which did not react with NHC-liganded gold.33 Also, entirely alkyl-substituted alcohols and 
acetates were reactive, so aryl group was not necessary. Instead, no rearrangements of primary or 
tertiary substrates were reported. Despite the limited substrate scope, the TA-Au method is highly 
interesting because of the low catalyst loading and affordable price of the ligand.  
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Scheme 18. TA-Au-catalyzed M-S rearrangement and equilibrium between ionic and neutral forms of TA-
Au.44 
 
Another special feature of TA-Au catalysts is the chemoselectivity, which allows coordination 
between gold and an alkyne, but not with an allene. As a consequence, stereoselectivity is dictated 
by the kinetic pathway, opposite to the thermodynamic pathway used by other gold catalysts. 
When α-haloenones were synthesized via propargylic acetate rearrangement followed by 
halogenation of allene, kinetically favored E isomers were formed with good to excellent 
selectivity.43 While other gold catalysts coordinate to the allene, the lack of coordination of TA-Au 
leaves this site open for the halogenating reagent. 
In conclusion, there are several gold catalyst systems, which give great results under mild 
conditions. Gold(I) complexes seem to be more reliable than gold(III). As the field of gold catalysis 
is still fresh and growing, better and more affordable methods are expected in near future. 
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3.3 Mercury and silver catalysts 
In addition to gold, late transition metals silver and mercury can act as soft Lewis acids and activate 
the triple bond. Although mercury sounds suspicious, one can recall that many organomercuric 
compounds are not toxic. Mercury(II) triflate catalyzes the M-S rearrangement of secondary 
ethoxyalkynyl acetates with good to excellent yields and practically perfect E-selectivity (Scheme 
19).46 Bulky t-butyl-substituted substrate gave only 45%. Primary, internal alkynyl acetates also 
react fairly well (51-84%, 5 examples),47 but the activating effect of electron-donating alkoxy group 
can be observed as better yields. Optimized conditions for the reaction of ethoxyalkynyl acetates 
at room temperature include 1 mol% of Hg(OTf)2, dichloromethane and 1 eq of water.  
 
 
Scheme 19. M-S rearrangement with Hg(OTf)2.46 
 
The mechanism for the rearrangement of the ethoxyalkynyl acetate is proposed to undergo through 
cyclization, which resembles the 1,3-shift already seen for various systems (Scheme 20; see Scheme 
9). After coordination of the alkyne with Hg(OTf)2, acetate attacks the triple bond to form a cyclic 
oxonium cation (58). Water attacks the carbonyl carbon, and subsequently, the ethoxy group helps 
with protonation to form another oxonium cation (60). Demercuration regenerates the catalyst, 
and fragmentation yields the unsaturated ester. The perfect E/Z stereoselectivity can be reasoned 
by noticing, that the side group prefers an equatorial orientation on the chair structure. 
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Scheme 20. Mechanism for the Hg(OTf)2-catalyzed M-S rearrangement.46 
 
A sophisticated method to activate a secondary or tertiary propargylic alcohol towards M-S 
rearrangement was introduced by Sugawara et al.48 Using 10 mol% of AgOMs and 1 eq of DBU in 
formamide under 1 MPa of CO2, high yields (70-98%) were obtained for several tertiary and 
secondary, internal propargylic alcohols with alkyl or ethoxy substituents (Scheme 21). The 
substrate with terminal alkyne was less reactive. Also DBN and DIPEA worked, and catalytic amount 
of base was sufficient at elevated temperature. No stereoselective control was observed.  
The hydroxyl group is converted into carbonate by carbon dioxide (Scheme 21). Silver salt activates 
the triple bond, and 3,3-sigmatropic rearrangement occurs in the presence of base to form an 
allene-enolate (64). Release of CO2 yields the enone. The incorporation of CO2 was proved by 
isotopic studies. A polar solvent is crucial to prevent the attack to the α carbon of the triple bond 
and the formation of a cyclic carbonate (63) (route B in Scheme 21). Polar solvents, like DMF and 
DMA, stabilize the polarized carbonate structure with an elongated C-O bond, which is directed to 
attack the β carbon. The drawback of the system is the high loading (10 mol%) of AgOMs. 
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Scheme 21. M-S rearrangement with silver salt and carbon dioxide, and an alternative fate.48 
  
4. Nonmetallic and metallic hard Lewis acids 
Lewis acid metal salts are very convenient choices for the M-S reaction, as they are easy to handle 
and sometimes recyclable from water. Among the tested salts, InCl3, Sc(OTf)3, FeCl3, Y(OTf)3 and 
Cu(OTf)2 are soluble in water, while Bi(OTf)3 and Ca(NTf2)2 are insoluble. During studies conducted 
by the group of Dudley,49 they implied that the tested salts act like soft Lewis acids and coordinate 
with the triple bond. It is more probable, though, that they coordinate with the hard hydroxyl 
oxygen, because In(III), Sc(III), Fe(III), Ca(II) and Y(III) are hard, while Cu(II) and Bi(III) are borderline 
Lewis acids. 
Scandium(III) triflate is a fast and efficient catalyst for ethoxylated propargylic alcohols.49 Exploiting 
one-pot olefination including alkynylation followed by M-S reaction, hindered α,β-unsaturated 
carbonyls can be synthesized, of which many cannot be prepared by traditional methods. It can be 
noticed that more hindered substrates exhibit even better chemoselectivity, as other mechanistic 
routes are inhibited. Copper(II) triflate give nearly similar results as scandium triflate. 
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During mechanistic studies for the Sc(OTf)3 catalyzed reaction, the group of Dudley conducted the 
same experiment as for the AuSBF6 (Scheme 8),19 in which substitution of ethanol by n-propanol 
resulted in 50% of n-propyl ester in the product. This time, 75% incorporation of n-propanol was 
observed and hence, a modified mechanism was proposed (Scheme 22). After the formation of a 
diethoxy allene (66), another equivalent of ethanol is added, which yields an ortho-ester (67), which 
in turn hydrolyzes to the unsaturated ester. 
 
 
Scheme 22. Mechanism for Sc(OTf)3-catalyzed M-S rearrangement.19 
 
Although not as active as scandium or copper, indium(III) chloride works well for ethoxy-activated 
propargylic alcohols.49 1 mol% of the catalyst in DCM/EtOH at room temperature catalyzed the M-
S reaction of the secondary ethoxydecynol 68 with 100% yield (Scheme 23a). Camphorsulfonic acid 
accelerated the reaction significantly. The mechanism could be assumed to be same type as with 
Sc(OTf)3. 
For nonactivated tertiary propargylic alcohol 70, InCl3 did not show any activity at 80 °C after 24 
hours (Scheme 23b).28 Nevertheless, terminal and internal alkynols with different aryl rings were 
transformed into enals and enones with excellent yields under microwave irradiation in water, in a 
timescale of 5 to 360 minutes (one example in Scheme 23c).50 The conditions tolerate aryl rings 
even with electron-withdrawing groups, therefore it would be tempting to consider MW irradiation 
for nonactivated substrates like 70, as well. Better solubility of substrates is based on superheating 
of water, which modifies its properties towards polar organic solvents.51 This green method would 
be highly recommended, although results might be unpredictable, as there are several influencing 
factors compared to traditional chemistry. 
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Scheme 23. Reactions of different substrates with InCl3: a) Ethoxy-activated49, b) alkyl-substituted28 and c) 
terminal, aryl-substituted50. 
 
Yttrium(III) triflate was used by Liu et al. to produce pyrazoles via hydrazones.52 The unsaturated 
hydrazones were produced either by aza-Meyer-Schuster reaction or M-S reaction of a propargylic 
alcohol followed by nucleophilic attack of tosyl hydrazide (Scheme 24). Also other salts of 
lanthanides Ce(III), Yb(III) and La(III) gave moderate yields. Lanthanide triflate salts have been called 
promising green catalysts, because of their selectivity and stability in water. Still, there are few 
examples of their use as catalyst. The major disadvantage is the high price. 
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Scheme 24. Y(OTf)3 catalyzed synthesis of hydrazones and their conversion into pyrazoles.52 
 
The same propargylic substitution/aza-Meyer-Schuster rearrangement reaction53, as well as M-S 
rearrangement of terminal and internal propargylic alcohols as part of formation of pyrroles54, have 
been catalyzed by 10 mol% iron(III) chloride. Additionally, El Douhaibi et al. studied reactions with 
stoichiometric amount of FeCl3.55 Therefore, success in catalytic utilization of FeCl3 in traditional M-
S rearrangement might be expected. The reactions require heating in tetrahydrofuran, 
dichloroethane or nitromethane. By using anhydrous conditions, El Douhaibi et al. proved that the 
catalyst is in fact FeCl3 and not HCl formed by hydrolysis. Alcaide et al. also demonstrated that 10 
mol% HCl in absence of FeCl3 did not induce desired transformation. 
Anhydrous conditions also rule out the hydration-dehydration mechanism. El Douhaibi et al. 
propose occurrence of an allylic cation intermediate (77) formed by the departure of the activated 
hydroxyl group (Scheme 25).55 
 
 
Scheme 25. Proposed mechanism for FeCl3-catalyzed M-S rearrangement.55 
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On the other hand, presence of traces of water has been shown indispensable in many occasions, 
anhydrous conditions leading to inhibition or other routes. This is true as well for a catalyst 
comprising Ca(NTf2)2/KPF6.56 Like Begouin and Niggemann explain, water hydrates the Lewis acid 
metal ion, which causes acidification of the water molecule.57 The resulting Lewis/Brønsted acid 
system has superior activity than either of the acids separately. Accordingly, the combination of 
FeCl3/HCl formed by partial hydrolysis could facilitate the M-S reaction. 
An exceptional feature in the study of Okamoto et al. is that primary propargylic alcohols with 
aromatic substitution on the acetylenic end were reactive upon treatment with several metal 
salts.58 There are only few examples of the M-S reactivity of primary substrates.25, 26 Bismuth(III) 
triflate was selected as the most promising catalyst in a tandem reaction including the M-S 
rearrangement and 1,4-addition of an alcohol. Also Cu(OTf)2, Al(OTf)3, Sc(OTf)3 and AgOTf showed 
activity.  
Electron-deficient fluorinated aryl boronic acids are a mild alternative for the M-S reaction of 
secondary and tertiary propargylic alcohols (Scheme 26).59 Boronic acid was seen to function 
together with a gold catalyst and especially enhance the E-selectivity,25, 26 but it works individually 
even at room temperature. 
 
 
Scheme 26. M-S rearrangement with boronic acid catalysts.59 
 
Another boron compound, BF3, has activity as a catalyst.60 During the synthesis of Taxol AB-ring 
system, ethoxylated substrate gave an α,β-unsaturated ester and a β-hydroxy ester. Although the 
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reaction proceeded at room temperature, BF3 is not a recommendable option because of its 
toxicity. 
 
5. Organometal complexes of transition metals 
In addition to gold, several transition metal-containing organometal complexes catalyze the Meyer-
Schuster rearrangement. By definition, organometallic compounds have at least one bond between 
a carbon atom and a metal. Ligands are coordinated with the metal ion with bonds that have both 
ionic and covalent character. The metals discussed in this chapter are ruthenium, rhenium and 
iridium, which are located next to each other on the second and third row of transition metal block, 
meaning that they have similar properties and various oxidation states. It has to be remembered 
that the following complexes used for the M-S rearrangement are not commercially available, and 
the use of these catalysts serves primarily for the investigation of the catalysts themselves. In 
addition, iridium and rhenium are very expensive. Therefore, they might not be reasonably 
deployed for common use. Nevertheless, they follow a special mechanism, which is suitable for 
terminal propargylic alcohols, and is worth mentioning. 
The pioneering work on ruthenium-catalyzed M-S rearrangement was done by the group of 
Dixneuf.61 Anti-Markovnikov addition to alkynes was achieved by tuning the Ru catalyst with 
hydrocarbon ligands, followed by the discovery of the M-S rearrangement.62, 63 The method includes 
addition of the benzoic carboxylate to the terminal propargylic alcohol catalyzed by Ru[η3-
CH3C(Me)CH2]2(dppe) (84) (Scheme 27). Allylic ligands in the Ru complex 84 are labile in acidic 
conditions and afford a vacant coordination site for the substrate. The ruthenium-alkyne 85 is 
transformed into the more stable ruthenium-vinylidene species 86 by 1,2-hydride shift, and this 
Fischer carbene-like structure is able to react by anti-Markovnikov addition of benzoic acid (Scheme 
28). Protonolysis affords a hydroxyalkenyl benzoate 83, which is then transformed into an enone in 
situ. 
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Scheme 27. M-S rearrangement of tertiary substrates with Ru[η3-CH3C(Me)CH2]2(dppe) complex.63 
 
 
Scheme 28. Catalytic cycle for the Ru[η3-CH3C(Me)CH2]2(dppe) complex.63 
 
There are two ways to form the α,β-unsaturated aldehyde: In the first method, the benzoate 
intermediate undergoes a concerted rearrangement upon heating at 110 °C. This method requires 
the Z isomer, as the rearrangement occurs through a cyclic structure (89) (Scheme 29). 
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Scheme 29. Concerted mechanism for the benzoate intermediate rearrangement into an enal.62 
 
More convenient method is to use a catalytic amount of acid (HBF4 or PTSA) (Scheme 30). The 
protonated hydroxyalkenyl benzoate (90) releases benzoic acid to form the α,β-enal (79). By this 
method, both Z and E benzoates are reactive. The method is suitable only for tertiary alcohols. 
 
 
Scheme 30. Acid-catalyzed route for enals.63 
 
Secondary alcohols react with a half-sandwich Ru(II) catalyst [RuClCp(PMe3)2] (94) in i-PrOH/H2O at 
100 °C, giving predominantly E isomers (Scheme 31), as shown by the Wakatsuki group.64 The 
drawback of this reaction is the high temperature needed and unreactivity of tertiary alkynols. 
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Scheme 31. M-S rearrangement of secondary substrates with [RuClCp(PMe3)2] complex.64 
 
One possible reaction mechanism is shown on Scheme 32. It includes anti-Markovnikov hydration 
of the terminal alkyne, and it is based on allenylidene and vinylidene intermediates and the group’s 
formerly proposed aldehyde synthesis mechanism.65, 66 Their mechanism involved protonation of 
the Ru(II)-(hydroxy)alkyne complex 95, followed by formation of the Ru(IV)-hydride-
(hydroxy)vinylidene intermediate 97 (Scheme 32). It is unclear, whether the dehydration of the 
initial hydroxyl group takes place before or after the hydration (upper or lower route, respectively). 
The first option would yield the Ru(IV)-allenylidene intermediate 98, which would be attacked by 
OH- to obtain 102 after tautomerization of 99. The attack on α-carbon is facilitated by weaker back-
donation ability of Ru(IV). Late dehydration would occur from the γ-hydroxyacyl complex 101 to 
form Ru(IV)-acyl 102. In both cases, reductive elimination liberates the enal (93) and recovers the 
Ru(II) active species. 
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Scheme 32. Catalytic cycle for the [RuClCp(PMe3)2] complex.64, 65, 66 
 
The outcome of the reaction of a propargylic alcohol with Ru depends on solvent, electronic 
properties of the ligands and substitution on the γ-carbon. The cationic 16 e- compound [Ru(η3-2-
C3H4Me)(CO)(dppf)][SbF6] (103) catalyzed formation of propargylic ethers, when alcohol was acting 
as a solvent and a nucleophile (Scheme 33).67, 68, 69 In undistilled THF under reflux, nearly 
quantitative rearrangement into enals occurred instead. Trifluoroacetic acid improved the catalytic 
activity. Secondary and tertiary propargylic alcohols were suitable, and thermodynamic E products 
were observed exclusively. Rupe rearrangement occurs if the propargylic alcohol bears a C-H bond 
in the β-position of the alcohol. Thus, a variety of substrates is excluded. This is a severe drawback 
of the method, while many other catalysts can suppress the Rupe route. Another fate in absence of 
water is dehydration and formation of enynes. 
The dictating E isomer is formed due to the addition of water to the allenylidene complex in a 
stereoselective manner. The mechanism was suggested the same as the dehydration-hydration 
mechanism of the Wakatsuki group (see Scheme 32). As the aforementioned half-sandwich Ru-
complex yields mostly E isomers too, it might be considered to proceed partly through dehydration-
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hydration process, and not vice versa. A substantial proof for the formation of the Ru-vinylidene 
complex is the unreactivity of substrates bearing an internal alkyne. 
 
 
Scheme 33. M-S rearrangement with Ru(η3-2-C3H4Me)(CO)(dppf)][SbF6] complex.68 
 
 The [Ru(η3-2-C3H4Me)(CO)(dppf)][SbF6] (103) complex has been used in tandem isomerization-
aldol condensations to construct conjugated dienones and diene-diones,70, 71 which in turn, were 
used in the synthesis of dyes.72 
Finally, a special case of reactivity of internal propargylic alcohols was shown by the Dixneuf 
group.73 Instead of a carbene-like structure, possibly a cationic intermediate was formed in the 
reaction with [(p-cymene)Ru(OTf)(CO)(PCy3)][OTf]. 
The cationic iridium complex [IrCp*(NCMe)2(PPh2Me)][PF6]2 (107) catalyzed the M-S reaction of 
terminal, tertiary propargylic alcohols with excellent yields at room temperature (Scheme 34).74 At 
least one phenylic R group was required. No stereoselectivity was noticed. As the reactions were 
made in anhydrous conditions, previously suggested formation of allenylidene and hydroxyacyl 
complexes by hydration/dehydration can be ruled out. Instead, intramolecular attack of the OH 
group at the α carbon gives a (hydroxy)alkenylcarbene complex (105), which tautomerizes into an 
acyl complex. 
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Scheme 34. Mechanism for Ir and Re-catalyzed M-S rearrangement and structures of the complexes.74, 75 
 
Cationic rhenium(I) complexes of type [Re(κ3-P,N,S-Ph2PCH2PPh2)(CO)3][SbF6] (R = Et, Ph) (108) 
catalyze the M-S reaction of terminal secondary and tertiary propargylic alcohols with high yields 
and E selectivity under microwave irradiation (Scheme 34).75 Also selective Rupe reaction was 
obtained for compounds bearing a C-H bond in the β-position. The reactions were successful also 
in the ionic liquid [BMIM][PF6] (BMIM = 1-butyl-3-methylimidazolium), enabling recycling of the 
catalyst up to 10 times. 
The reaction mechanism is similar to the mechanism of the Ir catalyst above (see Scheme 34), 
including formation of the (hydroxy)vinylidene complex, and probable subsequent intramolecular 
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attack of hydroxide. The difference in E selectivity between the Ir and Re catalysts remains a 
mystery. 
Ru, Re and Ir complexes catalyze the Meyer-Schuster rearrangement of primary substrates, 
including one example of secondary substrates. The special mechanistic feature is the formation of 
metal-allenylidene or metal-vinylidene intermediate. These catalysts may give good results for 
aromatic compounds, but the catalytic compounds have to be prepared beforehand. 
 
6. Oxo complexes 
The first real catalysts for the M-S rearrangement were metal oxides and oxo ligands, which 
activated the hydroxyl group of propargylic alcohols. Vanadium, rhenium, titanium and 
molybdenum oxides have shown good selectivity towards M-S rearrangement, but they have 
traditionally required high temperatures (>100 °C), which causes degradation of substrates and 
catalysts and, naturally, is not reasonable in terms of green chemistry.6, 76, 77, 78 
The widely accepted 3,3-rearrangement mechanism is similar to the propargylic acetate 
rearrangement with gold (Scheme 35; see Scheme 9). A metal-oxo-propargyloxo complex (109) is 
formed by transesterification between a propargylic alcohol and an oxo-metal precatalyst. 3,3-
sigmatropic rearrangement yields the allenyloxo intermediate (111), which donates the metal-oxo 
group to the next substrate. The resulting allenol (5) tautomerizes into an α,β-unsaturated product. 
It can be noticed that the competing Rupe rearrangement is not possible, when this mechanism is 
applied, leading to high M-S selectivity. 
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Scheme 35. General mechanism for oxo-metal complex catalysis.78 
 
Vanadium has been used in the form VO(OR)3, but it has suffered from thermal instability.79, 80 
Whether substrate or catalyst-specific, in some cases, it has been possible to run the reaction at 80 
°C.18, 81 Carrillo-Hermosilla and García-Álvarez also made an important improvement to the 
reactivity of the catalyst by substituting one of the alkoxide groups with chloride.81 The resulting 
VO(Cl)(OEt)2 has an exhaustive substrate scope of internal and terminal propargylic alcohols, giving 
yields of 95-99% (20 examples), but no stereoselectivity. The reactions were conducted in toluene 
under microwave irradiation at 80 °C. The catalyst was used by Alibés in the synthesis of 
sesquiterpenes.82 
cis-dioxomolybdenum(VI) compound needed an additive, preferably a sulfoxide, to catalyze the 
reaction of tertiary, terminal propargylic alcohols (Scheme 36).78 Additionally, carboxylic acid 
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improved the yields notably. The role of the additives remained unclear, but the other oxo ligand 
was suggested to stabilize the cyclic intermediate 110 (Scheme 35). MoO2(acac)2 gave the best 
results, although several other ligands worked as well. Despite the stabilizing effect of the cationic 
intermediate, phenyl-substituted substrate was incompatible, as well as a primary alcohol. The best 
results gave exceptionally alkyl-substituted, terminal propargylic alcohols. The nucleophilic attack 
of the oxygen of the metal ester to the triple bond can be less preferred, if the alkyne is connected 
to electron-donating R groups, such as ethoxide. 
 
 
Scheme 36. Scope of MoO2(acac)2-catalyzed M-S rearrangement.78 
 
A gold catalyst in combination with molybdenum affords great results at room temperature 
(Scheme 37).83, 84 The oxomolybdenum complex offers the carbonyl functionality by 1,3-shift, and 
gold activates the triple bond. The advantages of this method are mild reaction conditions, 
shortened reaction times and wide scope of substrates: Primary substrates react easily, and even a 
rare example of an N-alkynyl amide rearrangement is offered. The mild reaction conditions have 
been exploited in the synthesis of (+)-anthecotulide derivatives and platencin.85, 86, 87 
 
 34 
 
 
Scheme 37. Reaction scope and mechanism of Mo/Au-catalyzed M-S rearrangement.83, 84 
 
Same kind of coordination is shown by a combination of titanium alkoxide and copper(I) chloride 
(Scheme 38).6, 88 Ti(OR)4 is activated by carboxylic acid, and it gives a titanium propargyloxo complex 
with a propargylic alcohol substrate. CuCl coordinates with the triple bond and thus activates the 
complex (123) towards 3,3-sigmatropic rearrangement, which yields the α,β-unsaturated carbonyl 
compound. Again, high temperatures (130 °C) are needed, but the recyclable catalyst system brings 
benefit. The method seems promising in terms of substrates, as primary and tertiary, internal and 
terminal propargylic alcohols with alkyl R groups were reactive (4 examples). 
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Scheme 38. M-S rearrangement with Ti/Cu catalyst.6, 88 
 
Rhenium(VII) oxide can catalyze the M-S rearrangement in acidic conditions at room temperature 
(Scheme 39).89, 90 Tetrabutylammonium perrhenate (Bu4NReO4) with catalytic amount of p-
toluenesulfonic acid hydrate in dichloromethane gave good to excellent yields for tertiary and 
secondary phenyl-substituted propargylic alcohols, including (trialkylsilyl)alkyne alcohols. 
Secondary alkyl-substituted alcohols required heating up to accelerate the reaction, and primary 
substrates only gave a trace of product. Due to its chemoselectivity, perrhenate salt has been used 
in several total syntheses.79, 80 
 
 36 
 
 
Scheme 39. Perrhenate-catalyzed M-S rearrangement.89, 90 
 
The readily available rhenium(V) complex [ReOCl3(OPPh3)(SMe2)] has proven to be efficient catalyst 
for several secondary and tertiary substrates (Scheme 40).91 Although the reaction proceeds at 
room temperature, heating up to 80 °C accelerates the rate and improves the yield significantly. 
Being moderately coordinating, dimethoxyethane turned out to be the most suitable solvent. 
Reactions have high E-selectivity, and complete enantioselectivity can be achieved by prolonged 
treatment with the catalyst.  
 
 
Scheme 40. M-S rearrangement with [ReOCl3(OPPh3)(SMe2)].91 
 
The catalyst has shown applicability in tandem reactions, as well.92, 93, 94 Nolin et al.92 prepared 
enantioenriched allylic alcohols by one-pot rearrangement-reduction reaction by addition of chiral 
ligands into the mixture. They conducted also conjugate addition of thiols into enones to form β-
sulfanyl ketones.93 Vidari and co-workers94 used the alkynylation-rearrangement route already 
introduced by Dudley and co-workers49 to produce enones. 
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The generally accepted mechanism was supported by labeling tests, but as no free acid was 
detected in the reaction mixture arising from the chlorine-alkoxy ligand exchange, Stefanoni et al. 
proposed a modified mechanism (Scheme 41).91 First, the hydroxyl group of the substrate adds 
across the Re-oxo bond and, as a consequence, the resulting polarized complex 124 undergoes 
easily the 1,3-shift. Finally, the resulting allenol structure 5 leads to the enone. 
 
 
Scheme 41. Modified mechanism for [ReOCl3(OPPh3)(SMe2)]-catalyzed M-S rearrangement.91 
 
7. Conclusions 
As it can be seen, there are no general conditions for the Meyer-Schuster rearrangement. There 
are some guidelines for the substrate scope and temperature applied, but unfortunately, often one 
has to apply the “trial and error” approach. Generally, aryl and alkoxy-substituted propargylic 
alcohols react efficiently. Unactivated n-alkyl-substituted substrates tend to be very unreactive or 
suffer from the Rupe rearrangement. It may be advisable to transform them into acetates, which 
changes the mechanism applied. This, in turn, weakens the effort to apply only few synthetic steps. 
Activation of the hydroxyl group by protonation or with a Lewis acid is a traditional approach for 
the M-S rearrangement. A wide selection of different metal salts is available, and they are easy to 
use. The benefit of oxo metals is their high selectivity, but the harsh conditions are not suitable for 
all the substrates. Also strong Brønsted acids can find their applications in some simple cases. 
 38 
 
Recently, the attention has turned to the activation of the triple bond instead of the hydroxyl. As 
gold catalysis is still a relatively fresh field, new methods and lower catalyst loading may be 
expected also for the M-S rearrangement. Gold is not as expensive as platinum or palladium, which 
are used routinely in modern synthesis. Organometal complexes of ruthenium and similar metals 
would be a great choice for terminal alkynes, but practically these catalysts are not applicable 
without proficient organometallic chemistry skills. 
At the moment, there are few examples of Z selectivity,8, 43 and that is the most challenging theme 
for the future work. Most probably the selectivity could be developed based on sterically 
demanding ligands, which allow the electrophile attack on one side only. Additionally, microwave-
assisted reactions preferably in water are expected to be seen, following the lead of Cadierno et 
al.50 Some characters of the different catalyst groups are collected in Table 1.
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Table 1. Groups of M-S rearrangement catalysts and their utility. 
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Abbreviations 
3-MBA 3-methoxybenzamide 
4-DPPBA 4-diphenylphosphinobenzoic acid 
AIBN azobisisobutyronitrile 
BS-FtsZ Bacillus subtilis FtsZ 
dansyl (dimethylamino)naphthalene-1-sulfonyl 
dba dibenzylideneacetone 
DCM dichloromethane 
DMF dimethylformamide 
ESI electrospray ionization 
Et ethyl 
FtsZ filamenting temperature-sensitive mutant Z 
GDP guanosine 5’-diphosphate 
GMPCPP guanosine 5’-[(α,β)-methyleno]triphosphate 
GTP guanosine 5’-triphosphate 
HPLC high performance liquid chromatography 
IR infrared 
Me methyl 
MS mass spectrometry 
NBD nitrobenzoxadiazole 
NBS N-bromosuccinimide 
Ph phenyl 
PS polystyrene 
TLC thin-layer chromatography 
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1. Background and aim of the work 
FtsZ (filamenting temperature-sensitive mutant Z) is a bacterial homologue for eucaryotic tubulin.1 
This widely conserved GTPase has an essential role in bacterial cell division and has recently been 
proposed as an attractive target for antibacterial drug discovery.  
The function of FtsZ and the bacterial cell division have been reviewed by Errington and 
Lutkenhaus.2, 3 FtsZ exists in the bacterial cells as both monomers and highly ordered polymers, 
depending on whether it is bound to guanosine 5’-triphosphate (GTP) or guanosine 5’-diphosphate 
(GDP). At the earliest step of cell division, it undergoes self-assembly of individual subunits at the 
mid-cell, and GTP-binding promotes the FtsZ polymerization by head-to-tail association. On the 
contrary, when GTP is hydrolyzed to GDP, the protofilament adapts a curved conformation and 
disintegrates. The protofilaments polymerize in different shaped filaments leading to the formation 
of Z-ring, which is a highly dynamic structure with a half-time of a few seconds. Several other 
division proteins are then recruited to regulate and form the divisome, a complex that finally 
constricts to generate two new daughter cells. 
FtsZ is a tempting target for antibiotics, as it is the principal protein in Z-ring formation and 
cytokinesis. Over the last decade, several compounds have been identified as FtsZ inhibitors 
perturbing the protein polymerization and the GTPase activity. Schaffner-Barbero et al. and Li et al. 
have reviewed groups of molecules with antimicrobial activity based on FtsZ.4, 5 
The biggest contribution to the synthetic FtsZ inhibitors came from the development of 3-
methoxybenzamide (3-MBA) derivatives. Ohashi et al. found out that 3-MBA (Figure 1) inhibits 
weakly cell division in Bacillus subtilis in vitro.6 Based on this finding, Haydon et al. screened through 
more than 500 benzamide analogs.7 They found out that a compound PC190723 and its derivative 
8J (Figure 1) are potent inhibitors of staphylococci and Bacillus subtilis in vitro.7, 8 
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Figure 1. Structures of 3-MBA, PC190723 and 8J. 
 
The crystal structure of S. aureus FtsZ-GDP in complex with PC190723 has been reported (Figure 
2).9 PC190723 binds to a narrow pocket in FtsZ formed by the C-terminal half of the H7 helix, the 
T7 loop and the C-terminal four-stranded β-sheet. The difluorobenzamide substituent fits into the 
top portion of the cleft by directly interacting with the T7 loop. The chlorine at the lipophilic end 
enters into a hydrophobic tunnel formed by two residues from the H7 helix (Gln192 and Gly193) and 
two from the C-terminal β-sheet (Met226 and Ile228). The tunnel leads to a wide pocket, which could 
be structurally mapped to the equivalent of tubulin’s taxol-binding site. 
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Figure 2. A: Structure of FtsZ protein of S. Aureus with PC190723 (in magenta) and GDP (green). B: Detailed 
view of the PC190723-binding pocket.9 (Reprinted with permission of The American Association for the 
Advancement of Science.) 
 
PC190723 acts as an FtsZ polymer-stabilizing agent that modulates the flexibility and the assembly 
of the protein.10 It triggers a conformational change in which the H7 helix and the C-terminal 
domain move away from the N-terminal domain in the presence of GDP. The forming linear 
protofilament encloses GDP, which prevents dissociation of the filament. 
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The antibacterial activity of PC190723 seems to be caused by its 2,6-difluoro-3-hydroxybenzamide 
(DFMBA) moiety.11 The compound inhibits the GTPase activity at 10 μM and has been characterized 
as a potent selective bactericide. Notably, it is the first inhibitor shown to be efficacious in an in 
vivo model of bacterial infection.7 In this context, the Medical Chemistry Laboratory led by Prof. M. 
Luz López-Rodríguez started a project aimed at the discovery of FtsZ inhibitors targeting the GTP-
binding pocket and the PC190723 binding site. The present research project was focused on the 
last one, and the main objective was the design and synthesis of a set of fluorescent derivatives of 
inhibitors PC190723 and 8J, which could be used to obtain information about the interactions 
between the inhibitors and the protein. 
 
2. Results 
2.1 Design and preparation of the inhibitors 
The design of the compounds was started based on the structure of PC190723/8J and the previous 
work done by the research group. Thus, three sets of fluorescent derivatives that contain the 
DFMBA subunit were designed following three approaches (Figure 3): i) the replacement of the 
heterocyclic subunit of PC190723/8J by a fluorescent tag (Set I); ii) the attachment of a fluorophore 
through a spacer at position 5 of the benzothiazole of 8J, replacing the chlorine atom (Set II); iii) the 
attachment of the fluorescent tag to the position 6 of the benzothiazole using an amino group as 
bonding group (Set III). The selected fluorophores were a coumarin, dansyl (5-
(dimethylamino)naphthalene-1-sulfonyl) and nitrobenzoxadiazole (NBD).  
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Figure 3. Designed Sets I-III of fluorescent derivatives based on PC190723 and 8J. 
 
2.2 Synthesis of compounds of Set I 
Regarding the first set of fluorescent compounds, the heterocyclic subunit of PC190723/8J was 
replaced by a fluorophore and an ethyl chain bearing an amino group as attachment point was used 
as a spacer. The retrosynthetic analysis is presented in the Figure 4. 
 
 6 
 
 
Figure 4. Retrosynthetic analysis for Set I compounds. 
 
The commercially available 2,6-difluoro-3-methoxybenzoic acid (5) was first converted into its 
corresponding amide (6) via acid chloride (Scheme 1). Then, the methoxy group was deprotected 
with boron tribromide, and Mitsunobu reaction of the resulting phenol (7) with 
hydroxyethylphthalimide followed by removal of the protecting group afforded the corresponding 
amine (9). This 3-(2-aminoethoxy)-2,6-difluorobenzamide was further treated with Cl-NBD, dansyl 
chloride or 7-diethylaminocoumarin-3-carboxylic acid using the appropriate coupling-reaction 
conditions to afford the NBD (1a), dansyl (1b) and coumarin (1c) derivatives, respectively (Scheme 
2).  
 
 
Scheme 1. Synthesis of intermediate 9. 
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Scheme 2. Syntheses of fluorescent compounds 1a-c. 
 
2.3 Synthesis of compounds of Set II 
The compounds of Set II were constructed by attachment of the fluorophore to the position 5 of 
the benzothiazole ring of 8J by replacement of the chlorine atom and using an aliphatic spacer. The 
route for Set II compounds was adapted from Haydon et al.8 and Sorto et al.12, and the 
retrosynthetic analysis is shown on Figure 5. 
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Figure 5. Retrosynthetic analysis for Set II. 
 
The first task was to synthesize the N-protected intermediate amine 12 by reaction of 
propargylamine (10) with ethyl trifluoroacetate (11) (Scheme 3).  
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Scheme 342. Synthesis of N-protected amine 12. 
 
Commercial 5-bromo-2-methylbenzothiazole (13) was brominated with N-bromosuccinimide (NBS) 
in the presence of azobisisobutyronitrile (AIBN), followed by Williamson alkylation of intermediate 
14 with 2,6-difluoro-3-hydroxybenzamide (7) to afford derivative 15 (Scheme 4).8 Next, Sonogashira 
coupling reaction of 15 with 2,2,2-trifluoro-N-(prop-2-ynyl)acetamide (12) was explored under 
microwave conditions (Table 1 and Scheme 4). Carbon-supported palladium (Pd/C) and 4-
diphenylphosphinobenzoic acid (4-DPPBA) were firstly tested as catalytic system and unfortunately 
yielded no product. The coupling reaction was then tried with dipalladium-
tris(dibenzylideneacetone)chloroform complex [Pd2(dba)3·CHCl3] and polystyrene-supported 
triphenylphosphine (PS-PPh3) affording the desired compound 16 with 54% yield. Finally, the use of 
tetrakis(triphenylphosphine)palladium [(PPh3)4Pd] as catalyst yielded derivative 16 with high yield 
(86%). 
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Scheme 4. Synthesis of intermediate 16. 
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Table 1. Catalysts used for Sonogashira coupling of 15 and 12. 
 
Catalytic system Reaction conditions Yield (%) 
Pd/C, 4-DPPBA  CuI, Cs2CO3, DMF, H2O, 120 °C 
(MW), 15 min 
0 
Pd2(dba)3 · CHCl3, PS-PPh3 CuI, Et3N, DMF, 120 °C (MW), 1 h 54 
Pd(PPh3)4 CuI, Et3N, DMF, 100 °C (MW), 45 
min 
86 
 
 
Next, compound 16 was deprotected by reaction with ammonia solution and the intermediate 
amine 17 treated with dansyl chloride or 7-diethylaminocoumarin-3-carboxylic acid to obtain 
fluorescent derivatives 2a and 2b, respectively (Scheme 5).  
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Scheme 543. Syntheses of fluorescent compounds 2a and 2b. 
 
In order to study the influence of a more flexible spacer, the triple bond present in 16 was 
hydrogenated in the presence of Raney-Ni to afford aliphatic amide 18 (Scheme 6). Amino group 
was then deprotected, followed by condensation of the resulting amine with dansyl chloride to 
obtain the fluorescent derivative 3. 
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Scheme 6. Synthesis of fluorescent derivative 3. 
 
2.4 Synthesis of compounds of Set III 
In Set III, the fluorophore was attached to the position 6 of the benzothiazole ring of 8J using an 
amino group as attachment point. This route was also based on the synthesis described by Haydon 
et al.8 In this case, benzothiazole intermediate 24 bearing a nitro group was constructed by 
thionation of the corresponding amide 21 and subsequent cyclization (Figure 6). 
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Figure 6. Retrosynthetic analysis for Set III. 
 
 15 
 
During my stay, I managed to proceed to the compound 23 (Scheme 7).  The synthesis started with 
reaction of 2,5-dichloro-4-nitroaniline (19) with benzyloxyacetyl chloride (20) to yield the 
corresponding amide (21). Then, thionation of the carbonyl group with Lawesson’s reagent was 
followed by cyclization of intermediate 22 with NaH to get 2-((benzyloxy)methyl)-5-chloro-6-
nitrobenzo[d]thiazole (23). 
To terminate the synthesis of compounds of Set III, the proposed route includes bromination of 23, 
Williamson alkylation with 2,5-difluoro-3-hydroxybenzamide (7), reduction of the nitro group of 26 
and condensation with the fluorophore to yield the corresponding fluorescent derivatives 4 
(Scheme 7, dotted reaction arrows). 
 
 
Scheme 7. Synthesis of intermediate 23 and proposed synthesis of fluorescent compounds 4. 
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2.5 Biological evaluation 
Biological evaluation of the synthesized compounds was carried out in collaboration with the 
research group led by Dr. José Manuel Andreu at the “Centro de Investigaciones Biológicas” (CIB, 
Biological Research Center). First, the effect of compounds 1a-c, 2a-b and 3 on FtsZ assembly was 
investigated. This was done using Bacillus subtilis FtsZ (Bs-FtsZ) polymer sedimentation assays. 
Fluorescence spectra of the compounds were also measured in order to find potential probe 
molecules for future investigation. 
Polymer pelleting experiments were made by sedimenting the FtsZ polymers formed under well-
controlled assembly conditions in the presence of the compound under study and quantifying them 
after loading the pellets and supernatants with a time lag into polyacrylamide gel electrophoresis. 
Proportions of polymerized pellets in presence of the compounds were compared. Bs-FtsZ with GTP 
or GMPCPP (non-hydrolyzable form of GTP) and MgCl2 were used as basal controls. Also, PC190723 
or 8J were used as additional controls. Figure 7 shows the effect of compounds 1a-c and 2a on FtsZ 
assembly in the presence of GMPCPP. Compound 2a was the only compound able to inhibit FtsZ 
filament assembly by stabilizing filament polymerization, as the percentage of the pellet in 
sediment is larger than that of the control (91% of pellet in conditions 3 vs 69% in basal conditions 
D). 
 
 
Figure 7. Sedimentation assays for 1a-c and 2a. 
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The polymerization effects of dansyl derivatives 2a and 3 using GTP were also compared (Figure 8). 
It can be seen that compound 2a had some activity (69% of pellet in conditions 2 vs 56% in basal 
conditions B), whereas compound 3 showed no activity (24% of pellet in conditions 2). This result 
could be explained because of the flexibility of the hydrogenated chain of 3, which prevents the 
molecule from entering the cavity of action. It is noteworthy that compound 2a is active only in 
presence of GMPCPP or GTP and MgCl2 (data not shown), while PC190723 does not require MgCl2 
to induce formation of coil structures of FtsZ.11 These results demonstrate that fluorescent 
derivative 2a is an FtsZ polymer stabilizing agent and therefore an inhibitor of FtsZ activity. 
 
 
 
Figure 8. Sedimentation assays for 2a and 3. 
 
Fluorescence emission spectra for compounds 1a-c, 2a and 3 were measured to investigate 
wavelength and intensity displacements when binding to the protein (Figure 9A-E). Major changes 
of intensity and maximum wavelength were observed only for dansyl derivative 1b (Figure 9B, 
displacement between blue and red lines), while the other compounds show minor or no changes. 
At last, fluorescence anisotropy values (R) were measured for 1b-c, 2a and 3. The anisotropy values 
change significantly only for 1b, from 0.012 to 0.115 (Figure 9B), which indicates that this 
fluorescent compound binds to the protein. However, the presence of PC190723 does not restore 
the initial values, meaning that it is not able to replace the fluorescent derivative 1b. 
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Figure 9. Fluorescence emission spectra for compounds 1a-c, 2a and 3. A: Compound 1a (20 µM), λex = 474 
nm. B: Compound 1b (10 µM), λex = 306 nm. C: Compound 1c (10 µM), λex = 422 nm. D: Compound 3 (10 µM), 
λex = 345 nm. E: Compound 2a (10 µM), λex = 345 nm. 
 
3. Conclusions 
In this project, compounds 1a-c, 2a-b and 3 were synthesized. They are fluorescent derivatives of 
PC190723 and 8J, known FtsZ inhibitors. Synthetic route for Set III compounds was started as well. 
Compound 2a has an FtsZ polymer-stabilizing effect, and acts as an inhibitor. On the other hand, 
only 1b is capable of changing its fluorescent properties when binding to FtsZ. Hence, more accurate 
structural design based on the protein crystal structure is needed. There is little information about 
interactions between PC190723 and other bacterial FtsZ than S. aureus.13 Calculations made by 
Miguel et al.13 propose that the PC190723 binding pocket varies across species and polymerization 
states, and taking that into account, Bs-FtsZ may have different binding mechanism and place of 
action. More species-specific structural studies are needed to be able to design better fitting 
inhibitory molecules. 
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4. Experimental methods 
General methods: 
All chemicals were purchased from Sigma-Aldrich, ABCR, Acros, Lancaster, Invitrogen, ATTO-TEC or 
Scharlab and were used without further purification. Anhydrous dichloromethane and 
tetrahydrofuran were freshly distilled over sodium hydride and sodium benzophenone ketyl, 
respectively. Triethylamine was dried over calcium hydride and distilled prior use. Hydrogenation 
reactions were carried out with a Parr hydrogenator. Reactions under microwave irradiation were 
carried out in a Biotage Initiator 2.5 reactor. 
The reactions were followed with analytical thin-layer chromatography (TLC) on Merck silica gel 
plates (Kieselgel 60 F-254) with detection by UV light. Flash chromatography was performed on a 
Varian 971-FP flash purification system using SuperFlash Si50 silica gel cartridges. 
Melting points were determined on a Stuart Scientific electrothermal apparatus. IR spectra were 
measured on a Bruker Tensor 27 spectrometer equipped with a Specac ATR accessory of 5200-650 
cm-1 transmission range, and the frequencies are expressed in cm-1. Nuclear magnetic resonance 
(NMR) spectra were recorded on a Bruker DPX 300 (1H, 300 MHz; 13C, 75 MHz) and Bruker Avance 
500 (1H, 500 MHz; 13C, 125 MHz) at the Universidad Complutense de Madrid (UCM) NMR facilities. 
Chemical shifts (δ) are expressed in parts per million relative to internal tetramethylsilane. Coupling 
constants (J) are in hertz (Hz). 
Mass spectrometry (MS) was carried out on a Bruker LC-Esquire spectrometer in electrospray 
ionization (ESI) mode at the UCM’s mass spectrometry core faciliy. High performance liquid 
chromatography coupled to mass spectrometry (HPLC-MS) analysis was performed using an Agilent 
1200LC-MSD VL instrument. LC separation was achieved with an Zorbax Eclipse XDB-C18 column (5 
μm, 4.6 mm x 150 mm) for naphthalene derivatives and a Zorbax SB-C3 column (5 μm, 2.1 mm x 50 
mm) for biphenyl derivatives, both together with a guard column (5 μm, 4.6 mm x 12.5 mm). The 
gradient mobile phases consisted of A (95:5 water/MeOH) and B (5:95 water/MeOH) with 0.1% 
ammonium hydroxide and 0.1% formic acid as the solvent modifiers. MS analysis was performed 
with an ESI source. The capillary voltage was set to 3.0 kV and the fragmentor voltage was set at 72 
eV. The drying gas temperature was 350 °C, the drying gas flow was 10 L/min, and the nebulizer 
pressure was 20 psi. Spectra were acquired in positive or negative ionization mode from 100 to 
1200 m/z and in UV-mode at four different wavelengths (210, 230, 254, and 280 nm).  
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Elemental analyses (C, H, N, S) were obtained on a LECO CHNS-932 apparatus at the UCM’s 
Elemental Microanalysis services. Purity of final compounds was determined by elemental analyses 
and HPLC-MS, confirming at least a 95% of purity. 
 
4.1 Set I 
2,6-Difluoro-3-methoxybenzamide (6): 
 
 
 
To a suspension of 2,6-difluoro-3-methoxybenzoic acid 5 (1 g, 5.32 mmol) in anhydrous toluene (8 
mL) thionyl chloride (580 µL, 7.98 mmol) was added slowly under an argon atmosphere. The 
reaction mixture was refluxed for 5 hours. The solvent was evaporated under reduced pressure on 
a rotary evaporator. Then, the residue was dissolved in tetrahydrofuran (2 mL), 28% aqueous 
ammonia solution (4 mL) was added and the mixture was stirred at room temperature for 14 hours. 
The solvent was evaporated under reduced pressure and the resulting precipitate was suspended 
in water and filtered. The collected solid was dried under vacuum to afford 2,6-difluoro-3-
methoxybenzamide 6 as a white solid in 80% yield. 
Melting point: 167-169 °C. 
IR (ATR): 3386 (NH2), 3180 (NH2), 1651 (CO), 1590, 1491, 1452 (Ar). 
1H NMR ((CD3)2CO, 300 MHz) δ: 3.88 (s, 3 H, OCH3), 6.97 (td app, J = 9.0; 2.0, 1 H, C5H), 7.18 (td app, 
J = 9.3; 5.1, 2 H, C4H, NH), 7.44 (s br, 1 H, NH). 
13C NMR ((CD3)2CO, 125 MHz) δ: 57.1 (CH3), 111.4 (dd, J = 23.1; 4,2, C5H), 115.1 (d, J = 9.4; 2,8, C4H), 
117.3 (t, J = 21.6, C1), 145.3 (dd, J = 11.0; 3.2, C3), 149.5 (dd, J = 250.1; 8.1, CF), 153.4 (dd, J = 241.6; 
6.5, CF), 162.2 (CONH2). 
MS (ESI): 188.1 [M+H]+. 
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2,6-Difluoro-3-hydroxybenzamide (7): 
 
 
 
A solution of boron tribromide in dichloromethane (1 M, 8.6 mL, 8.60 mmol) was added dropwise 
to a solution of 2,6-difluoro-3-methoxybenzamide 6 (805 mg, 4.30 mmol) in anhydrous 
dichloromethane (25 mL) under an argon atmosphere. The mixture was stirred for 3 days at room 
temperature. The solvent was evaporated under reduced pressure on a rotary evaporator, the 
residue was dissolved in ethyl acetate (2 x 40 mL) and then washed with water (40 mL). The organic 
layer was dried with sodium sulfate, filtered and concentrated on a rotary evaporator. The residue 
was purified by silica gel column chromatography (hexane → hexane/ethyl acetate 3:7) to obtain 
2,6-difluoro-3-hydroxybenzamide 7 as a white solid in 79% yield. 
Melting point: 123-124 °C. 
IR (ATR): 3196 (NH2), 1666 (CO), 1598, 1493, 1394 (Ar). 
1H NMR ((CD3)2CO, 300 MHz) δ: 6.87 (td app, J = 8.8; 1.8, 1 H, C5H), 7.01 (td app, J = 9.2; 5.4, 1 H, 
C4H), 7.17 (s a, 1 H, CONH2), 7.41 (s a, 1 H, CONH2), 8.79 (s, 1 H, OH). 
13C NMR ((CD3)2CO, 125 MHz) δ: 111.7 (dd, J = 23.3; 4.0, C5H), 117.0 (t, J = 21.6, C1), 118.7 (dd, J = 
9.1; 3.7, C4H), 142.3 (dd, J = 13.5; 3.2, C3), 148.5 (dd, J = 245.4; 7.9, CF), 152.6 (dd, J = 240.3; 6.2, 
CF), 162.4 (CONH2). 
MS (ESI): 172.0 [M-H]-. 
 
3-[2-(1,3-Dioxoisoindolin-2-yl)ethoxy]-2,6-difluorobenzamide (8): 
 
 
 
 
To a solution of 2,6-difluoro-3-hydroxybenzamide 7 (292 mg, 1.69 mmol), N-(2-
hydroxyethyl)phthalimide (478 mg, 2.50 mmol) and triphenylphosphine (873 mg, 3.33 mmol) in 
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anhydrous tetrahydrofuran (10 mL), diethyl azodicarboxylate (DEAD) (610 µL, 3.33 mmol) was 
added under an argon atmosphere. The mixture was refluxed for 24 hours. The solvent was 
evaporated under reduced pressure on a rotary evaporator and the residue was purified by silica 
gel column chromatography (hexane → hexane/ethyl acetate 1:1) to afford 3-[2-(1,3-
dioxoisoindolin-2-yl)ethoxy]-2,6-difluorobenzamide 8 as a white solid in 51% yield. 
Melting point: 169-171 °C. 
IR (ATR): 3397 (NH2), 1710 (CO), 1655 (CO), 1492 (Ar). 
1H NMR ((CD3)2CO, 300 MHz) δ: 4.01 (t, J = 5.7, 2 H, CH2N), 4.29 (t, J = 5.7, 2 H, CH2O), 5.82 (s br, 1 
H, NH2), 5.97 (s br, 1 H, NH2), 6.85 (td app, J = 9.1; 1.8, 1 H, C5H), 7.05 (td app, J = 9.0; 5.1, 1 H, C4H), 
7.74 (dd, J = 5.4; 3.0, 2 H, 2HPht), 7.87 (dd, J = 5.5; 2.9, 2 H, 2HPht). 
13C NMR ((CD3)2CO, 75 MHz) δ: 37.9 (CH2N), 67.7 (OCH2), 111.6 (dd, J = 23.5; 3.9, C5H), 116.9 (t, J = 
23.5, C1), 117.1 (d, J = 7.1, C4H), 123.9 (2 CHPht), 133.0 (2 CPht), 135.2 (2 CHPht), 144.0 (dd, J = 10.8; 
3.2, C3), 150.6 (dd, J = 251.0; 8.9, CF), 153.0 (dd, J = 242.0; 6.5, CF), 162.0 (d, J = 6.7, CONH2), 168.6 
(2 COPht). 
Elemental Analysis of C17H12F2N2O4: Calculated (%): C: 58.96; H: 3.49; N: 8.09. Observed (%): C: 
58.41; H: 3.93; N: 7.78. 
MS (ESI): 347.1 [M+H]+. 
 
3-(2-Aminoethoxy)-2,6-difluorobenzamide (9) 
 
 
 
To a mixture of 3-[2-(1,3-dioxoisoindolin-2-yl)ethoxy]-2,6-difluorobenzamide 8 (180 mg, 0.52 
mmol) in ethanol (15 mL), monohydrated hydrazine (50.6 µL, 1.04 mmol) was added. The reaction 
mixture was refluxed for 2 hours and then, the solvent was evaporated under reduced pressure. 
The crude was purified by silica gel column chromatography (ethyl acetate → ethanol) to obtain 3-
(2-aminoethoxy)-2,6-difluorobenzamide 9 as a white solid in 87% yield. 
Melting point: 98-100 °C. 
IR (ATR): 3310 (NH2), 1675 (CO), 1489 (Ar). 
1H NMR (CD3OD, 500 MHz) δ: 3.22 (t, J = 5.1, 2 H, CH2NH2), 4.20 (t, J = 5.1, 2 H, CH2O), 6.99 (td app, 
J = 8.9; 1.9, 1 H, C5H), 7.23 (td app, J = 9.2; 5.2, 1 H, C4H). 
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13C NMR (CD3OD, 125 MHz) δ: 40.8 (CH2NH2), 70.1 (OCH2), 112.1 (dd, J = 22.4; 4.5, C5H), 117.1 (t, J 
= 23.8, C1), 118.3 (dd, J = 9.4; 2.4, C4H), 144.1 (dd, J = 11.0; 3.3, C3), 150.7 (dd, J = 252.8; 9.0, CF), 
154.6 (dd, J = 244.0; 5.8, CF), 165.1 (CONH2). 
MS (ESI): 216.9 [M+H]+. 
 
2,6-Difluoro-3-{2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]ethoxy}benzamide (1a) 
 
 
To a solution of 3-(2-aminoethoxy)-2,6-difluorobenzamide 9 (101 mg, 0.47 mmol) and triethylamine 
(71.3 µL, 1.51 mmol) in anhydrous dimethylformamide (3 mL), a solution of 4-chloro-7-nitro-1,2,3-
benzoxadiazole (93 mg, 0.47 mmol) in anhydrous dimethylformamide (1 mL) was added under 
argon atmosphere. The mixture was stirred at room temperature protected from light for 22 hours. 
The solvent was evaporated under reduced pressure on a rotary evaporator. The crude was purified 
by silica gel column chromatography (dichloromethane → dichloromethane/ethyl acetate 1:1), and 
2,6-difluoro-3-{2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]ethoxy}benzamide 1a was obtained as a 
brown solid in 18% yield. 
Melting point: 169-172 °C. 
IR (ATR): 3354 (NH2), 1676 (CO), 1586, 1491 (Ar). 
1H NMR ((CD3)2CO, 500 MHz) δ: 4.16 (m, 2 H, CH2N), 4.54 (t, J = 5.2, 2 H, CH2O), 6.67 (d, J = 8.7, 1 H, 
CHNBD), 6.98 (td app, J = 8.9; 2.1, 1 H, C5H), 7.17 (s br, 1 H, NH), 7.26 (td app, J = 9.1; 5.1, 1 H, C4H), 
7.41 (s br, 1 H, NH), 8.52 (d, J = 8.7, 1 H, CHNBD). 
13C NMR ((CD3)2CO, 125 MHz) δ: 43.8 (CH2NH), 68.5 (OCH2), 100.0 (CHNBD), 111.1 (dd, J = 23.2; 4.1, 
C5H), 116.3 (d, J = 9.6, C4H), 116.9 (t, J = 25.7, C1), 123.5 (CNBD), 137.2 (CHNBD), 143.6 (dd, J = 11.2; 
3.4, C3), 144.7 (CNBD), 145.1 (CNBD), 145.4 (CNBD), 149.3 (dd, J = 248.6; 8.3, CF), 153.3 (dd, J = 242.4; 
6.3, CF), 161.6 (CONH2). 
Elemental Analysis of C17H12F2N2O4: Calculated (%): C: 47.50; H: 2.92; N: 18.47. Observed (%): C: 
47.40; H: 3.29; N: 18.13. 
MS (ESI): 379.7 [M+H]+, 396.6 [M+Na]+. 
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3-[2-({[5-(Dimethylamino)-1-naphthyl]sulfonyl}amino)ethoxy]-2,6-difluorobenzamide (1b) 
 
 
 
3-(2-aminoethoxy)-2,6-difluorobenzamide 9 (98 mg, 0.45 mmol) was dissolved in anhydrous 
dimethylformamide (3 mL) under an argon atmosphere. A solution of triethylamine (0.19 mL) and 
dansyl chloride (183 mg, 0.68 mmol) in anhydrous dimethylformamide (1 mL) was added, and the 
reaction mixture was stirred at room temperature for 22 hours. Afterward, the solvent was 
evaporated under reduced pressure and the crude was purified by silica gel column 
chromatography (dichloromethane) to afford 3-[2-({[5-(dimethylamino)-1-
naphthyl]sulfonyl}amino)ethoxy]-2,6-difluorobenzamide 1b in 10% yield. 
Melting point: 130-132 °C. 
IR (ATR): 3316 (NH2), 1744 (CO), 1582, 1502, 1459 (Ar). 
1H NMR (CDCl3, 500 MHz) δ: 2.89 (s, 6 H, 2 CH3), 3.38 (q app, J = 5.5, 2 H, CH2N), 3.85 (t, J = 5.0, 2 H, 
CH2O), 5.25 (t, J = 6.0, 1 H, NH), 6.77-6.85 (m, 2 H, C4H, C5H), 7.17 (d, J = 7.2, 1 H, C6’H), 7.52 (t, J = 
7.9, 1 H, C3’H/C7’H), 7.57 (t, J = 8.0, 1 H, C3’H/C7’H), 8.24-8.27 (m, 2 H, C4’H, C6’H), 8.54 (d, J = 7.2, 1 
H, C2’H). 
13C NMR (CDCl3, 125 MHz) δ: 43.2 (CH2N), 45.6 (2 CH3N), 68.9 (OCH2), 111.3 (dd, J = 20.6; 4.5, C5H), 
115.5 (CHDs), 118.6 (C1), 120.4 (dd, J = 9.1; 3.5, C4H), 123.4 (CHDs), 128.8 (CHDs), 129.5 (2 CDs), 129.6 
(2 CHDs), 130.1 (CDs), 130.8 (CHDs), 135.1 (CDs), 142.9 (dd, J = 9.3; 3.5, C3), 153.0 (dd, J = 262.9; 4.6, 
C2/C6), 156.7 (dd, J = 255.0; 2.9, C2/C6), 164.7 (CONH2). 
Elemental Analysis of C17H12F2N2O4: Calculated (%): C: 56.12; H: 4.71; N: 9.35; S: 7.13. Observed (%): 
C: 57.17; H: 5.16; N: 8.29; S: 6.43. 
MS (EI): 432.1 [M+H]+. 
HPLC tr (min): 20.71. 
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N-{2-[3-(aminocarbonyl)-2,4-difluorophenoxy]ethyl}-7-(diethylamino)-2-oxo-2H-chromene-3-
carboxamide (1c) 
 
 
To a solution of 3-(2-aminoethoxy)-2,6-difluorobenzamide 9 (80 mg, 0.37 mmol) in anhydrous 
dimethylformamide (5 mL), N,N-diisopropylethylamine (DIPEA) (129 µL, 0.74 mmol), bromo-tris-
pyrrolidino-phosphoniumhexafluorophosphate (PyBrOP) (310.5 mg, 0.66 mmol) and 7-
(diethylamino)coumarin-3-carboxylic acid (100 mg, 0.38 mmol) were added under an argon 
atmosphere. The reaction mixture was stirred at room temperature for 4 hours. The solvent was 
evaporated under reduced pressure and the crude was purified by silica gel column 
chromatography (dichloromethane → dichloromethane/ethyl acetate 9:1) to afford N-{2-[3-
(aminocarbonyl)-2,4-difluorophenoxy]ethyl}-7-(diethylamino)-2-oxo-2H-chromene-3-carboxamide 
1c in 27% yield. 
Melting point: 155-158 °C. 
IR (ATR): 3366 (NH2), 1704, 1663 (CO), 1618, 1583, 1537 (Ar). 
1H NMR (DMSO-d6, 700 MHz) δ: 1.14 (t, J = 7.0, 6 H, 2 CH3), 3.48 (q, J = 7.0, 4 H, 2 CH2), 3.70 (q, J = 
5.7, 2 H, CH2N), 4.18 (t, J = 5.7, 2 H, CH2O), 6.61 (d, J = 2.0, 1 H, CHcoum), 6.81 (dd, J = 9.0; 2.2, 1 H, 
CHCoum), 7.07 (t app, J = 8.8, 1 H, C5H), 7.29 (td app, J = 9.3; 5.3, 1 H, C4H), 7.69 (d, J = 9.0, 1 H, CHCoum), 
7.85 (s br, 1 H, NH), 8.13 br (s, 1 H, NH), 8.69 (s, 1 H, CHCoum), 8.93 (t, J = 5.7, 1 H, NH). 
13C NMR (DMSO-d6, 175 MHz) δ: 12.3 (2 CH3), 38.3 (CH2N), 44.3 (CH2NH), 68.3 (OCH2), 95.9 (CHCoum), 
107.7 (CCoum), 109.0 (CCoum), 110.2 (CHCoum), 111.0 (dd, J = 22.6; 4.0, C5H), 115.6 (d, J = 9.4, C4H), 116.7 
(dd, J = 25.1; 20.3, C1), 131.7 (CHCoum), 142.8 (dd, J = 10.6; 2.7, C3), 147.9 (CHCoum), 148.0 (dd, J = 
248.5; 9.0, CF), 152.0 (dd, J = 241.7; 7.2, CF), 152.5 (CCoum), 157.3 (CCoum), 161.3 (CONH2), 161.8 (CO), 
162.6 (CO). 
Elemental Analysis of C23H23F2N3O5: Calculated (%): C: 60.13; H: 5.05; N: 9.15. Observed (%): C: 
60.23; H: 5.41; N: 8.44. 
MS (EI): 459.6 [M+H]+. 
HPLC tr (min): 18.86. 
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4.2 Set II 
2,2,2-Trifluoro-N-(prop-2-ynyl)acetamide (12) 
 
 
 
To a solution of propargylamine 10 (2 g, 36.3 mmol) in anhydrous methanol (5 mL) at 0 °C stirring 
under an argon atmosphere, ethyl trifluoroacetate (3.82 mL, 36.3 mmol) was added dropwise. The 
mixture was stirred at room temperature for 17 hours. The solvent was evaporated under reduced 
pressure on a rotary evaporator and the crude was purified by silica gel column chromatography 
(dichloromethane) to obtain 2,2,2-trifluoro-N-(prop-2-ynyl)acetamide 12 in 60% yield. 
Melting point: liquid. 
IR (ATR): 3305 (NH), 1711 (CO), 1553 (NH). 
1H NMR (CDCl3, 300 MHz) δ: 2.32 (d, J = 2.6, 1 H, CH), 4.13 (dd, J = 5.3; 2.5, 2 H, CH2), 6.80 (s br, 1 H, 
NH). 
13C NMR (CDCl3, 75 MHz) δ: 29.8 (CH2), 73.3 (CH), 77.4 (C), 115.7 (q, J = 288.0, CF3), 157.1 (q, J = 
37.4, CO). 
MS (EI): 150.0 [M+H]+. 
HPLC tr (min): 11.39. 
 
5-Bromo-2-(bromomethyl)benzo[d]thiazole (14) 
 
 
To a solution of 2-methyl-5-bromobenzothiazole 13 (5.00 g, 22.04 mmol) in CCl4 (90 mL), N-
bromosuccinimide (8.00 g, 44.94 mmol) and azobisisobutyronitrile (0.75 g, 4.57 mmol) were added 
under an argon atmosphere, and the reaction was stirred at 90 °C for 3 hours. Afterwards, the 
solvent was evaporated under reduced pressure. The crude was purified by silica gel column 
chromatography (hexane → hexane/ethyl acetate 95:5) to afford 5-bromo-2-
(bromomethyl)benzo[d]thiazole 14 in 13% yield. 
IR (ATR): 1730, 1583, 1542, 1507, 1435 (Ar). 
1H NMR (CDCl3, 300 MHz) δ: 4.79 (s, 2 H, CH2), 7.54 (dd, J = 8.6; 1.8, 1 H, C6H), 7.74 (d, J = 8.6, 1 H, 
C7H), 8.17 (d, J = 1.8, 1 H, C4H). 
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13C NMR (CDCl3, 75 MHz) δ: 27.0 (CH2), 120.3 (C5), 123.0 (C7H), 126.6 (C4H), 129.1 (C6H), 135.3 (C7a), 
154.2 (C3a), 168.3 (C2). 
MS (ESI): 307.8 [M+H]+. 
HPLC tr (min): 22.97. 
 
3-((5-Bromobenzo[d]thiazol-2-yl)methoxy)-2,6-difluorobenzamide (15) 
 
 
 
5-Bromo-2-(bromomethyl)benzo[d]thiazole 14 (943 mg, 3.07 mmol) was dissolved in dry 
dimethylformamide (15 mL) in a round-bottomed flask and 2,6-difluoro-3-hydroxybenzamide 7 
(532 mg, 3.07 mmol) and potassium carbonate (1274 mg, 9.21 mmol) were added under an argon 
atmosphere. The mixture was stirred at room temperature overnight. Then, the solvents were 
evaporated under reduced pressure. The brown solid was purified by silica gel column 
chromatography (hexane → ethyl acetate → methanol) to obtain 3-((5-bromobenzo[d]thiazol-2-
yl)methoxy)-2,6-difluorobenzamide 15 in 94% yield. 
IR (ATR): 3373 (NH2), 3189, 1669 (CO), 1591, 1524, 1490 (Ar). 
1H NMR (DMSO, 300 MHz) δ: 5.70 (s, 2 H, CH2), 7.10 (td app, J = 9.0; 1.8, 1 H, C5H), 7.39 (td app, J = 
9.4; 5.2, 1 H, C4H), 7.64 (dd, J = 8.6; 1.9, 1 H, C6’H), 7.87 (s br, 1 H, NH), 8.13 (d, J = 8.6, 1 H, C7’H), 
8.15 (s br, 1 H, NH2), 8.25 (d, J = 1.9, 1 H, C4’H). 
13C NMR (DMSO, 75 MHz) δ: 68.6 (CH2), 111.1 (dd, J = 23.4; 4.1, C5H), 116.3 (dd, J = 9.4; 1.9, C4H), 
116.8 (dd, J = 24.8; 20.3, C1), 119.2 (C5’), 124.4 (C7’H), 125.3 (C4’H), 128.3 (C6’H), 133.7 (C7a’), 141.9 
(dd, J = 11.0; 3.3, C3), 148.1 (dd, J = 248.9; 9.1, CF), 152.5 (dd, J =242.2; 7.1, CF), 153.7 (C3a’), 161.1 
(C2’), 169.9 (CONH2). 
MS (ESI): 400.8 [M+H]+. 
HPLC tr (min): 19.75. 
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2,6-Difluoro-3-((5-(3-(2,2,2-trifluoroacetamido)prop-1-ynyl)benzo[d]thiazol-2-
yl)methoxy)benzamide (16): 
 
 
 
a) Pd(PPh3)4 as catalyst: 
2,2,2-Trifluoro-N-(prop-2-ynyl)acetamide 12 (397 mg, 2.63 mmol), 3-((5-bromobenzo[d]thiazol-2-
yl)methoxy)-2,6-difluorobenzamide 15 (350 mg, 0.88 mmol), 
tetrakis(triphenylphosphine)palladium(0) (101 mg, 0.09 mmol) and copper(I) iodide (87 mg, 0.46 
mmol) were mixed in a microwave vial and purged with argon. Anhydrous dimethylformamide (15 
mL) and triethylamine (0.2 mL, 1.13 mmol) were added and the mixture was heated at 100 °C under 
MW radiation for 45 minutes. The solvent was evaporated under reduced pressure and the brown 
residue was purified by silica gel column chromatography (hexane → ethyl acetate) to afford 2,6-
difluoro-3-((5-(3-(2,2,2-trifluoroacetamido)prop-1-ynyl)benzo[d]thiazol-2-yl)methoxy) benzamide 
16 in 86% yield. 
IR (ATR): 3301 (NH2), 1716 (CO), 1679 (CO), 1553, 1489, 1439 (Ar). 
1H NMR (DMSO, 300 MHz) δ: 4.32 (d, J = 5.6, 2 H, CH2NH), 5.70 (s, 2 H, CH2O), 7.11 (td app, J = 8.9; 
1.8, 1 H, C5H), 7.39 (td app, J = 9.3; 5.2, 1 H, C4H), 7.51 (dd, J = 8.4; 1.5, 1 H, C6’H), 7.88 (s br, 1 H, 
NH), 8.07 (d, J = 1.1, 1 H, C4’H), 8.16 (d, J = 8.3, 1 H, C7’H), 8.17 (s br, 1 H, NH), 10.10 (t, J = 5.3, 1 H, 
NHCH2). 
13C NMR (DMSO, 175 MHz) δ: 29.4 (CH2NH), 68.6 (CH2O), 82.1 (C≡C), 85.3 (C≡C), 111.1 (dd, J = 23.2; 
4.0, C5H), 116.2 (d, J = 9.3, C4H), 116.6-117.0 (m, C1, CF3), 119.9 (C5’), 123.1 (C7’H), 125.5 (C4’H), 128.3 
(C6’H), 135.1 (C7a’), 141.9 (dd, J = 11.0; 3.2, 1 C, C3), 148.3 (dd, J = 248.7; 8.4 , CF), 152.3 (dd, J =242.2; 
7.1 , CF), 152.7 (C3a’), 156.2 (d, J = 37.0, COCF3), 161.1 (C2’), 169.3 (CONH2). 
MS (ESI): 469.6 [M+H]+. 
HPLC tr (min): 17.64. 
 
b) Pd/C as catalyst: 
3-((5-Bromobenzo[d]thiazol-2-yl)methoxy)-2,6-difluorobenzamide 15 (101.7 g, 0.25 mmol), cesium 
carbonate (191.4 mg, 0.57 mmol), 4-diphenylphosphinobenzoic acid (16.5 mg, 46 µmol), 10% 
 30 
 
palladium/carbon (1.7 mg, 11 µmol), copper(I) iodide (10.1 mg, 46 µmol), dimethylformamide (3 
mL) and water (4 mL) were mixed in a microwave vial and purged with argon for 30 minutes. 2,2,2-
Trifluoro-N-(prop-2-ynyl)acetamide 12 (36 mg, 228 µmol) in 1 mL of dimethylformamide was 
added. The mixture was heated in the microwave at 120 °C for 15 minutes. The mixture was filtered 
through Celite, and the organic and aqueous layers were separated. According to the HPLC-MS 
analysis, there was no product in either of the two phases. 
 
b) Pd2(dba)3·CHCl3 and PS-PPh3 as catalyst: 
Polystyrene-supported triphenylphosphine (19 mg, 38 µmol), copper(I) iodide (4 mg, 38 µmol) and 
tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct (5 mg, 38 µmol) were mixed in a 
microwave vial and purged with argon. 3-((5-Bromobenzo[d]thiazol-2-yl)methoxy)-2,6-
difluorobenzamide 15 (76 mg, 0.19 mmol), triethylamine (1 mL), 2,2,2-trifluoro-N-(prop-2-
ynyl)acetamide 12 (150 mg, 0.95 mmol) and anhydrous dimethylformamide (2 mL) were added and 
the mixture was purged with argon. The reaction was heated at 120 °C in the microwave for 1 hour. 
After that, there was still some starting material left, and the heating was repeated. The mixture 
was filtered through Celite and solvents were evaporated. The product was dried under vacuum 
overnight and the dark brown liquid was purified by silica gel column chromatography (hexane → 
ethyl acetate) to afford 2,6-difluoro-3-((5-(3-(2,2,2-trifluoroacetamido)prop-1-
ynyl)benzo[d]thiazol-2-yl)methoxy)benzamide 16 in 54% yield. 
Spectroscopic data as earlier. 
 
3-((5-(3-Aminoprop-1-yn-1-yl)benzo[d]thiazol-2-yl)methoxy)-2,6-difluorobenzamide (17) 
 
 
 
2,6-Difluoro-3-((5-(3-(2,2,2-trifluoroacetamido)prop-1-ynyl)benzo[d]thiazol-2-
yl)methoxy)benzamide 16 (150 mg, 0.32 mmol) was dissolved in methanol (30 mL) and 28% 
aqueous ammonia solution (22 mL) was added. The light green solution was stirred at room 
temperature overnight. Afterward, solvents were evaporated under reduced pressure and the 
crude was triturated with diethyl ether to afford 3-((5-(3-aminoprop-1-ynyl)benzo[d]thiazol-2-
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yl)methoxy)-2,6-difluorobenzamide 17 in 92% yield, which was used in the next step without 
purification. MS (EI): 374.1 [M+H]+. 
 
3-((5-(3-(5-(Dimethylamino)naphthalene-1-sulfonamido)prop-1-ynyl)benzo[d]thiazol-2-
yl)methoxy)-2,6-difluorobenzamide (2a) 
 
 
 
3-((5-(3-Aminoprop-1-ynyl)benzo[d]thiazol-2-yl)methoxy)-2,6-difluorobenzamide 17 was dissolved 
in a mixture of anhydrous dimethylformamide (1 mL) and dichloromethane (2 mL), and 
triethylamine (62 µL, 0.442 mmol) was added under an argon atmosphere. Then, a solution of 
dansyl chloride (60 mg, 0.221 mmol) in anhydrous dichloromethane (1 mL) was added. The reaction 
mixture was stirred at room temperature for 20 hours. The solvents were evaporated under 
reduced pressure. The residue was dissolved in dichloromethane and washed with saturated 
aqueous sodium bicarbonate. The organic layer was dried with sodium sulfate, filtered and 
concentrated. The crude was purified by silica gel column chromatography (dichloromethane → 
ethyl acetate) to afford 3-((5-(3-(5-(dimethylamino)naphthalene-1-sulfonamido)prop-1-
ynyl)benzo[d]thiazol-2-yl)methoxy)-2,6-difluorobenzamide 2a as a yellow solid in 28% yield. 
Melting point: 194-196 °C. 
IR (ATR): 1739, 1681 (CO), 1489, 1461 (Ar) 
1H NMR (DMSO, 700 MHz) δ: 2.67 (s, 6 H, 2 CH3), 4.04 (d, J = 4.9, 2 H, CH2N), 5.67 (s, 2 H, CH2O), 
6.79 (dd, J = 8.3; 1.4, 1 H, CHDs), 7.12 (t app, J = 9.0, 1 H, C5H), 7.21 (d, J = 7.4, 1 H, CHDs), 7.27 (d, J = 
0.8, 1 H, C4’H), 7.38 (td app, J = 9.2; 5.1, 1 H, C4H), 7.58-7.63 (m, 2 H, C6’H, CHDs), 7.90 (s br, 1 H, NH), 
7.96 (d, J = 8.3, 1 H, C7’H),  8.17 (s br, 1 H, NH), 8.22 (dd, J = 7.2; 1.0, 1 H, CHDs),  8.32 (d, J = 8.6, 1 H, 
CHDs), 8.36 (d, J = 8.6, 1 H, CHDs), 8.53 (t, J = 5.0, 1 H, NHSO2).  
13C NMR (DMSO, 175 MHz) δ: 32.4 (CH2N), 44.9 (2 CH3), 68.5 (CH2O), 82.2 (C≡C), 86.3 (C≡C), 111.2 
(dd, J = 25.0; 2.9, C5H), 115.0 (CHDs), 116.2 (d, J = 8.7, C4H), 116.9 (dd, J = 25.5; 20.0, C1), 119.2 (CHDs), 
119.6 (C5’), 122.6 (C7’H), 123.6 (C4’H), 124.9 (C6’H), 127.7 (CHDs), 127.8 (CHDs), 129.0 (CHDs), 129.4 
(CDs), 129.8 (CHDs), 132.1 (C7’a), 134.7 (CDs), 136.0 (CDs), 142.3 (dd, J = 10.8; 2.4, C3), 148.0 (dd, J = 
248.8; 8.4, CF), 151.4 (CDs), 152.1 (C3a’), 152.5 (dd, J = 243.1; 6.7, CF), 161.1 (C2’), 169.0 (CONH2). 
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Elemental Analysis of C30H24F2N4O4S2: Calculated (%): C: 59.39; H: 3.99; N: 9.24; S: 10.57. Observed 
(%): C: 60.57; H: 4.27; N: 7.93; S: 8.77 (impurity Ph3PO). 
MS (EI): 607.1 [M+H]+. 
HPLC tr (min): 14.78. 
 
N-(3-(2-((3-carbamoyl-2,4-difluorophenoxy)methyl)benzo[d]thiazol-5-yl)prop-2-ynyl)-7-
(diethylamino)-2-oxo-2H-chromene-3-carboxamide (2b) 
 
 
 
To a solution of 3-((5-(3-aminoprop-1-ynyl)benzo[d]thiazol-2-yl)methoxy)-2,6-difluorobenzamide 
17 (119 mg, 0.32 mmol) in anhydrous dimethylformamide (5 mL), DIPEA (0.1 mL, 0.64 mmol), 
PyBrOP (268 mg, 0.57 mmol) and 7-(diethylamino)coumarin-3-carboxylic acid (100 mg, 0.38 mmol) 
were added under an argon atmosphere. The mixture was stirred at room temperature for 4 hours. 
The solvent was evaporated under vacuum, and the crude was purified by silica gel column 
chromatography (dichloromethane/ethyl acetate 1:1) to obtain N-(3-(2-((3-carbamoyl-2,4-
difluorophenoxy)methyl)benzo[d]thiazol-5-yl)prop-2-ynyl)-7-(diethylamino)-2-oxo-2H-chromene-
3-carboxamide 2b in 5% yield. 
Melting point: 248-249 °C. 
1H NMR (DMSO, 700 MHz) δ: 1.17 (t, J = 7.0, 6 H, 2 CH3), 3.50 (q, J = 6.9, 4 H, 2 CH2 coum), 4.43 (d, J = 
5.5, 2 H, CH2NH), 5.71 (s, 2 H, CH2O), 6.64 (d, J = 2.0, 1 H, CHcoum), 6.83 (dd, J = 8.9; 2.1, 1 H, CHcoum), 
7.13 (t app, J = 8.8, 1 H, C5H), 7.40 (td app, J = 9.1; 5.1, 1 H, C4H), 7.52 (dd, J = 8.3; 1.1, 1 H, C6’H), 
7.72 (d, J = 9.1, 1 H, CHcoum), 7.90 (s br, 2 H, NH2), 8.08 (s, 1 H, CH4’), 8.16 (d, J = 8.4, 1 H, C7’H), 8.18 
(s br, 2 H, NH2), 8.72 (s, 1 H, CHcoum), 9.00 (t, J = 5.5, 1 H, NH). 
13C NMR (DMSO, 175 MHz) δ: 12.3 (2 CH3), 29.2 (CH2NH), 44.4 (2 CH2N), 68.8 (CH2O), 81.1 (C≡C), 
87.5 (C≡C), 95.9 (CHcoum), 107.7 (Ccoum), 108.8 (Ccoum), 110.2 (CHcoum), 111.1 (dd, J = 24.3; 4.2, C5H), 
116.2 (d, J = 9.9, C4H), 117.6-118.0 (m, C1), 120.4 (C5’), 123.0 (C7’H), 125.4 (C4’H), 128.4 (CHcoum), 
132.0 (C6’H), 134.8 (C7a’), 141.8-142.1 (m, C3), 148.2 (CHcoum), 149.2 (d, J = 265.5, CF), 152.5 (d, J = 
242.0, CF), 152.5 (C3a’), 152.6 (Ccoum), 157.4 (Ccoum), 161.1 (CONH2), 161.7 (CONH), 162.2 (COcoum), 
169.2 (C2’). 
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Elemental Analysis of C32H26F2N4O5S: Calculated (%): C: 57.31; H: 4.81; N: 8.35 S: 4.78. Observed (%): 
C: 57.21; H: 4.55; N: 7.96; S: 4.58. 
MS (EI): 617.2 [M+H]+. 
HPLC tr (min): 23.27. 
 
2,6-Difluoro-3-((5-(3-(2,2,2-trifluoroacetamido)propyl)benzo[d]thiazol-2-yl)methoxy)benzamide 
(18) 
 
 
 
Raney-Ni was added to a solution of 2,6-difluoro-3-((5-(3-(2,2,2-trifluoroacetamido)prop-1-
ynyl)benzo[d]thiazol-2-yl)methoxy)benzamide 16 (250 mg, 0.53 mmol) in a mixture of anhydrous 
tetrahydrofuran (20 mL) and methanol (40 mL) under an argon atmosphere, and the mixture was 
hydrogenated for 3 hours (1 bar). Then, the mixture was filtered through Celite and concentrated 
under reduced pressure. The crude was purified by silica gel column chromatography (hexane → 
ethyl acetate) to afford 2,6-difluoro-3-((5-(3-(2,2,2-trifluoroacetamido)propyl)benzo[d]thiazol-2-
yl)methoxy)benzamide 18 in 22% yield. 
IR (ATR): 3303 (NH), 1710, 1680 (CO), 1490 (Ar). 
1H NMR (MeOD, 300 MHz) δ: 1.96 (q app, J =  7.5, 2 H, CH2CH2CH2), 2.82 (t, J = 7.7, 2 H, CH2Ar), 3.34 
(t, J = 7.2, 2 H, CH2N), 5.57 (s, 2 H, CH2O), 6.97 (td app, J = 8.9; 1.8, 1 H, C5H), 7.32 (td app, J = 9.2; 
5.0, 1 H, C4H), 7.35 (dd, J = 8.3; 1.3, 1 H, C6’H), 7.57 (s, 1 H, NHCO), 7.84 (s, 1 H, C4’H), 7.92 (d, J = 8.3, 
1 H, C7’H). 
13C NMR (MeOD, 75 MHz) δ: 31.7 (CH2), 33.8 (CH2Ar), 40.3 (CH2NH), 70.4 (CH2O), 112.1 (dd, J = 23.7, 
3.7 , C5H), 117.0-117.2 (m, C1), 117.6 (q, J = 286, CF3) 118.7 (d, J = 9.2, C4H), 123.2 (C7’H), 127.8 (C4’H), 
130.0 (C6’H), 133.9 (C5’), 141.7 (C7’a), 143.8 (dd, J = 11.2; 2.4, C3), 150.7 (dd, J = 252; 8.2, CF), 154.2 
(C3’a), 154.9 (dd, J = 250; 6.6, CF), 159.0 (d, J = 36.8, COCF3), 165.0 (C2’), 169.7 (CONH2). 
MS (EI): 473.7 [M+H]+. 
HPLC tr (min): 20.27. 
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3-((5-(3-((5-(Dimethylamino)naphthalene)-1-sulfonamido)propyl)benzo[d]thiazol-2-
yl)methoxy)-2,6-difluorobenzamide (3) 
 
via 3-((5-(3-Aminopropyl)benzo[d]thiazol-2-yl)methoxy)-2,6-difluorobenzamide: 
 
 
To a solution of 2,6-difluoro-3-((5-(3-(2,2,2-trifluoroacetamido)propyl)benzo[d]thiazol-2-
yl)methoxy)benzamide 18 (61 mg, 0.13 mmol) in methanol (16 mL),  28% aqueous ammonia 
solution (7.8 mL) was added, and the reaction was stirred at room temperature overnight. Then, 
the solvent was evaporated under vacuum to afford 3-((5-(3-aminopropyl)benzo[d]thiazol-2-
yl)methoxy)-2,6-difluorobenzamide in 99% yield, which was used without purification. MS (EI): 
378.1 [M+H]+. 
 
 
 
To a solution of 3-((5-(3-aminopropyl)benzo[d]thiazol-2-yl)methoxy)-2,6-difluorobenzamide (52 
mg, 0.14 mmol) in a mixture of anhydrous dimethylformamide (1 mL) and dichloromethane (2 mL), 
triethylamine (58 µL, 0.41 mmol) was added under an argon atmosphere. Then, a solution of dansyl 
chloride (56 mg, 0.21 mmol) in anhydrous dichloromethane (1 mL) was added dropwise, and the 
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mixture was stirred at room temperature for 22 hours. After this time, the solvent was evaporated 
under reduced pressure, and the crude was purified by silica gel column chromatography 
(dichloromethane → ethyl acetate) to afford 3-((5-(3-((5-(dimethylamino)naphthalene)-1-
sulfonamido)propyl)benzo[d]thiazol-2-yl)methoxy)-2,6-difluorobenzamide 3 in 13% yield. 
Melting point: 185-186 °C. 
IR (ATR): 3435 (NH), 1670 (C=O), 1604, 1486, 1450 (Ar). 
1H NMR (DMSO, 700) δ: 1.58 (qt app, J = 7.2, 2 H, CH2CH2CH2), 2.55 (t, J = 7.7, 2 H, CH2Ar), 2.82 (s, 6 
H, 2 CH3), 2.83 (t, J = 7.3, 2 H, CH2N), 5.66 (s, 2 H, CH2O), 7.02 (dd, J = 8.2; 1.5, 1 H, CHDs), 7.10 (t app, 
J = 9.0, 1 H, C5H), 7.26 (d, J = 7.3, 1 H, CHDs), 7.38 (td app, J = 9.2; 5.1, 1 H, C4H), 7.57-7.62 (m, 3 H, 
CHDs, C4’H, C6’H), 7.89 (s br, 1 H, NH), 7.92 (d, J = 8.2, 1 H, C7H), 8.01 (t, J = 5.9, 1 H, NHSO2), 8.07 (dd, 
J = 7.1; 1.1, 1 H, CHDs), 8.18 (s br, 1 H, NH), 8.33 (d, J = 8.7, 1 H, CHDs), 8.45 (d, J = 8.44, 1 H, CHDs). 
13C-RMN (DMSO, 175 MHz) δ: 31.1, 31.8 (CH2CH2Ar), 41.8 (CH2N), 45.1 (2 CH3), 68.5 (CH2O), 111.1 
(d, J = 21.6, C5H), 115.1 (CHDs), 116.2 (d, J = 21.6, C4H), 116.8 (t, J = 23,4, C1), 119.1 (CHDs), 122.0 
(C7’H), 123.6 (C4’H), 126.2 (C6’H), 127.9 (2 CHDs), 128.3 (CHDs), 129.1 (CDs, C5’), 129.4 (CHDs), 131.9 
(C7a’), 136.1 (CDs), 140.1 (CDs), 142.0 (d, J = 9.0, C3), 148.0 (dd, J = 249.5; 7.7, CF), 151.4 (CDs), 152.9 
(C3a’), 152.4 (d, J = 240.4, CF), 161.1 (C2’), 167.4 (CON). 
Elemental Analysis of C30H28F2N4O4S2: Calculated (%): C: 59.00; H: 4.62; N: 9.17; S: 10.50. Observed 
(%): C: 58.41; H: 4.63; N: 9.17; S: 10.19. 
MS (EI): 611.2 [M+H]+. 
HPLC tr (min): 21.13. 
 
 
4.3 Set III 
2-(Benzyloxy)-N-(2,5-dichloro-4-nitrophenyl)acetamide (21) 
 
 
 
A solution of 2,5-dichloro-4-nitroaniline 19 (7.32 g, 35.4 mmol) in anhydrous dichloromethane (100 
mL) was cooled in an ice bath and triethylamine (7.5 mL, 53.8 mmol) was added under an argon 
atmosphere. Then, a solution of benzyloxyacetyl chloride (5 mL, 31.7 mmol) in anhydrous 
dichloromethane (35 mL) was added dropwise to the former, and the reaction mixture was stirred 
at room temperature for 22 hours. Afterward, the mixture was washed with water (50 mL) and 
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brine (50 mL). The organic phase was dried with sodium sulfate, filtered and concentrated under 
vacuum to yield a yellow solid, which was purified by silica gel column chromatography (hexane → 
hexane/ethyl acetate 95:5 → ethyl acetate) to afford 2-(benzyloxy)-N-(2,5-dichloro-4-
nitrophenyl)acetamide 21 in 26% yield. 
IR (ATR): 3362 (NH), 1705 (CO), 1574-1506 (Ar). 
1H NMR (CDCl3, 300 MHz) δ: 4.10 (s, 2 H, COCH2), 4.64 (s, 2 H, CH2Ph), 7.27-7.36 (m, 5 H, CHPh), 8.01 
(s, 1 H, C6H), 8.77 (s, 1 H, C3H), 9.22 (s, 1 H, NH). 
13C NMR (CDCl3, 75 MHz) δ: 69.4, 74.0 (2 CH2), 120.8 (CCl), 122.4, 126.6 (C3H, C6H), 127.9 (2 CHBn), 
128.6 (CCl), 128.7 (CHPh), 128.8 (2 CHBn), 136.1 (CNH), 138.3 (CPh), 142.3 (CNO2), 168.2 (CO). 
MS (EI): 378 [M+Na]+. 
HPLC tr (min): 24.08. 
 
2-(Benzyloxy)-N-(2,5-dichloro-4-nitrophenyl)ethanethioamide (22) 
 
 
 
2-(Benzyloxy)-N-(2,5-dichloro-4-nitrophenyl)acetamide 21 (1.15 g, 3.24 mmol) was dissolved in 
anhydrous toluene (30 mL) and Lawesson’s reagent (1.31 g, 3.24 mmol) was added under an argon 
atmosphere. The mixture was refluxed for 13.5 hours, and after that stirred at room temperature 
for 6 hours. Then, it was filtered through a short path of silica gel, washing with dichloromethane. 
The solvents were evaporated under reduced pressure to obtain a brown liquid, which was purified 
by silica gel column chromatography (hexane → hexane/ethyl acetate 7:3 → ethyl acetate) to 
obtain 2-(benzyloxy)-N-(2,5-dichloro-4-nitrophenyl)ethanethioamide 22 in 71% yield. 
IR (ATR): 3263 (NH), 1575, 1514, 1513 (Ar). 
1H NMR (CDCl3, 300 MHz) δ: 4.47 (s, 2 H, CSCH2), 4.72 (s, 2 H, CH2Ph), 7.30-7.39 (m, 5 H, CHPh), 8.08 
(s, 1 H, C3H), 9.71 (s, 1 H, C6H), 10.58 (s, 1 H, NH). 
13C NMR (CDCl3, 75 MHz) δ: 73.8, 77.3 (2 CH2), 123.5 (CCl), 124.0 (C6H), 126.7 (C3H), 127.2 (CCl), 
128.1 (2 CHPh), 128.8 (CHPh), 128.9 (2 CHPh), 136.2 (CPh), 138.5 (CNH), 143.5 (CNO2), 198.3 (CS). 
EM (ESI): 370.7 [M+H]+. 
HPLC tr (min): 25.51. 
 
2-((Benzyloxy)methyl)-5-chloro-6-nitrobenzo[d]thiazole (23) 
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2-(Benzyloxy)-N-(2,5-dichloro-4-nitrophenyl)ethanethioamide 22 (670 mg, 1.81 mmol) was 
dissolved in N-methyl-2-pyrrolididone (14 mL) under an argon atmosphere, and 60% sodium 
hydride in mineral oil (50 mg, 1.25 mmol) was added slowly. The mixture was refluxed for 1 hour, 
and then 20 mg of sodium hydride were added and reflux was continued for 0.5 hours. After cooling 
down the reaction to room temperature, ice-water was added, and the aqueous phase was 
extracted four times with ethyl acetate. The combined organic phases were washed with brine, 
dried with sodium sulfate, filtered and evaporated under reduced pressure to obtain dark brown 
crude, which was purified by silica gel column chromatography (hexane → hexane/ethyl acetate 
86:14 → ethyl acetate) to afford 2-((benzyloxy)methyl)-5-chloro-6-nitrobenzo[d]thiazole 23 in 17% 
yield. 
IR (ATR): 1727 (CN), 1545, 1461 (Ar). 
1H NMR (CDCl3, 300 MHz) δ: 4.76, 4.94 (s, 4 H, 2 CH2), 7.33-7.42 (m, 5 H, CHPh), 8.11 (s, 1 H, C3H), 
8.47 (s, 1 H, C6H). 
13C NMR (CDCl3, 75 MHz) δ: 69.4, 73.9 (2 CH2), 119.8 (C7H), 125.1 (CCl), 125.6 (C4H), 128.1 (2 CHPh), 
128.5 (CHPh), 128.8 (2 CHPh), 133.6 (C7a), 136.7 (CPh), 144.9 (CNO2), 155.7 (C3a), 178.2 (C2). 
 
 
3.4 Biological evaluation 
Expression and purification of Bs-FtsZ and polymer pelleting assays were carried out as described 
by Andreu et al. (2010).11 Fluorescence measurements were performed with Horiba-Jovin-Yvon 
Fluoromax-4 spectrofluorometro at 25 ˚C with sample volumes of 500 µL in cuvettes of 10 x 2 mm. 
The excitation wavelengths were selected according to absorption spectra previously registered. 
The measurements were made with concentrations of 10 µM for the compound of interest (except 
20 µM for 1a), 10 µM Bs-FtsZ, 10 µM MgCl2, 10 µM PC190723 or 8J, 0.1 mM GMPCCP or GTP in 50 
mM HEPES, pH 6.8 in the presence of 2% DMSO.  
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6. Appendix 
 
Figure A 1. 1H NMR spectrum of 6. 
 
Figure A 2. 13C NMR spectrum of 6.  
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Figure A 3. IR spectrum of 6. 
 
Figure A 4. 1H NMR spectrum of 7. 
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Figure A 5. 13C NMR spectrum of 7. 
 
 
Figure A 6. IR spectrum of 7. 
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Figure A 7. 1H NMR spectrum of 8. 
 
Figure A 8. 13C NMR spectrum of 8. 
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Figure A 9. IR spectrum of 8. 
 
Figure A 10. 1H NMR spectrum of 9. 
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Figure A 11. 1H NMR spectrum of 1a. 
 
Figure A 12. 13C NMR spectrum of 1a. 
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Figure A 13. 1H NMR spectrum of 1b. 
 
Figure A 14. 13C NMR spectrum of 1b. 
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Figure A 15. IR spectrum of 1b.  
 
Figure A 16. 1H NMR spectrum of 1c. 
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Figure A 17. 13C NMR spectrum of 1c. 
 
Figure A 18. IR spectrum of 1c. 
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Figure A 19. 1H NMR spectrum of 12. 
 
Figure A 20. 13C NMR spectrum of 12. 
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Figure A 21. IR spectrum of 12. 
 
Figure A 22. 1H NMR spectrum of 14. 
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Figure A 23. 13C NMR spectrum of 14. 
 
Figure A 24. IR spectrum of 14. 
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Figure A 25. 1H NMR spectrum of 15. 
 
Figure A 26. 13C NMR spectrum of 15. 
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Figure A 27. IR spectrum of 15. 
 
Figure A 28. 1H NMR spectrum of 16. 
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Figure A 29. 13C NMR spectrum of 16. 
 
Figure A 30. IR spectrum of 16. 
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Figure A 31. 1H NMR spectrum of 2a. 
 
Figure A 32. 13C NMR spectrum of 2a. 
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Figure A 33. IR spectrum of 2a. 
 
Figure A 34. 1H NMR spectrum of 2b. 
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Figure A 35. 13C NMR spectrum of 2b. 
 
Figure A 36. 1H NMR spectrum of 18. 
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Figure A 37. 13C NMR spectrum of 18. 
 
Figure A 38. IR spectrum of 18. 
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Figure A 39. 1H NMR spectrum of 3. 
 
Figure A 40. 13C NMR spectrum of 3. 
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Figure A 41. IR spectrum of 3. 
 
Figure A 42. 1H NMR spectrum of 21. 
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Figure A 43. 13C NMR spectrum of 21. 
 
Figure A 44. IR spectrum of 21. 
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Figure A 45. 1H NMR spectrum of 22. 
 
Figure A 46. 13C NMR spectrum of 22. 
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Figure A 47. IR spectrum of 22. 
 
Figure A 48. 1H NMR spectrum of 23. 
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Figure A 49. 13C NMR spectrum of 23. 
 
Figure A 50. IR spectrum of 23. 
 
